2018

(2017/11/01)

i

EBM

50

009592-01_GL___DIC95.indd 1 17/09/25 19:36

i

2009TNM20131201342017TNM8HPVp16EBER

Quality of Life

201710

009592-01_GL___DIC95.indd 1 17/09/25 19:36

11

1 11

2 11

3 11

4 12

5 13

6 13

15

1 15

2 15

19

A

A-1 19

1 19

2 19

3 20

4 21

A-2 22

1 22

2 23

A-3 26

1 26

2 26

3 27

A-4 28

1 28

2 29

3 30

A-5 33

1 33

2 33

3 36

4 37

5 39

A-6 41

1 41

2 42

B 45

B-1 45

1 45

2 47

47

B-2 49

1 49

2 51

51

B-3 53

1 53

2 54

54

B-4 56

1 56

2 58

59

B-5 62

1 62

2 63

65

B-6 68

1 68

2 70

72

B-7 75

1 75

2 76

3 78

B-8 83

1 83

2 84

3 85

85

B-9 87

1 87

2 88

89

91

1 91

CQ1-1 N CT 91

CQ1-2 T MRI 92

CQ1-3 93

CQ1-4 94

CQ1-5 95

CQ1-6 FDG-PET 96

CQ1-7 98

CQ1-8 100

2 102

CQ2-1 102

CQ2-2 104

CQ2-3 106

CQ2-4 III

108

CQ2-5 N1

109

CQ2-6 111

CQ2-7 112

CQ2-8 114

3 116

CQ3-1

116

CQ3-2 117

4 119

CQ4-1

119

CQ4-2 120

CQ4-3 II 122

CQ4-4 123

5 125

CQ5-1-1 HPV 125

CQ5-1-2 HPV 125

CQ5-1-3 HPV 125

6 127

CQ6-1 127

CQ6-2 128

7 130

CQ7-1 130

CQ7-2 131

CQ7-3 132

8 135

CQ8-1 1 cm 135

CQ8-2 137

CQ8-3

138

CQ8-4 140

CQ8-5 142

9 146

CQ9-1 146

CQ9-2 147

CQ9-3 148

CQ9-4 149

10 152

CQ10-1 152

CQ10-2 p16 EBER-ISH 153

CQ10-3 154

CQ10-4

155

11 157

CQ11-1

157

CQ11-2

158

CQ11-3

TPF TXTCDDP5-FUTXT

159

CQ11-4

161

CQ11-5 Cmab

163

CQ11-6

165

CQ11-7 166

CQ11-8 PD-1 168

12 170

CQ12-1 170

CQ12-2

171

CQ12-3 173

CQ12-4 CRT 175

CQ12-5 176

CQ12-6 178

CQ12-7 180

1

1

2

3

,-1 -2 TNMT-2-9

009592-01_GL_01_DIC95_.indd 1 17/09/25 19:31

11/181

2

TNM 6 1 6 2TNM 8 3CQ2001PubMedCQCQCQ

CQ

RCT 1

A B C1 C2 C3 D

4 20132

009592-01_GL_01_DIC95_.indd 2 17/09/25 19:31

12/181

3

5

6 1 7 22010 42016 5 6

6

1 62018 2 72015 3 Sobin LH, Wittekind ChUICCTNMTNM8

2017 4 20101

2010 5 201642016 6 2015

009592-01_GL_01_DIC95_.indd 3 17/09/25 19:31

13/181

14/181

1

1

XUSCTMRICTMRICTMRIMRI1-3

USUS4,5CTMRI

CTMRIT16-1112,13

USCTMRI

XPET-CT14-21X

XCTCTMRI

2 1995714.5

1

009592-01_GL_02_DIC95_.indd 1 17/09/25 19:31

15/181

22,23

1 ZupiA,CalifanoL,MaremontiP,etal.Accuracyinthediagnosisofmandibularinvolvementbyoralcancer.JCraniomaxillofacSurg.199624281-4.

2 LeslieA,FyfeE,GuestP,etal.StagingofSquamousCellCarcinomaoftheOralCavityandOrophar-ynxAComparisonofMRIandCTinT-andN-Staging.JComputAssistTomogr.19992343-9.

3 BolzoniA,CappielloJ,PiazzaC,etal.Diagnosticaccuracyofmagneticresonanceimagingintheas-

sessmentofmandibularinvolvementinoral-oropharyngealsquamouscellcarcinomaaprospectivestudy.ArchOtolaryngolHeadNeckSurg.2004130837-43.

4 ParkJS,SonKR,NaDG,etal.Performanceofpreoperativesonographicstagingofpapillarythyroidcarcinomabasedon thesixtheditionof theAJCCUICCTNMclassification system.AJRAmJRoentgenol.200919266-72.

5 SeiberlingKA,DutraJC,GunnJ.Ultrasound-guidedfineneedleaspirationbiopsyofthyroidnodulesperformedintheoffice.Laryngoscope.2008118228-31.

6 CastelijnsJA,GerritsenGJ,KaiserMC,etal.Invasionoflaryngealcartilagebycancercompari-sonofCTandMRimaging.Radiology.1988167199-206.

7 FerriT,DeThomasisG,QuarantaN,etal.ThevalueofCTscansinimprovinglaryngoscopyinpa-tientswithlaryngealcancer.EurArchOtorhinolaryngol.1999256395-9.

8 GironJ,JoffreP,Serres-CousineO,etal.CTandMRevaluationoflaryngealcarcinomas.JOtolaryn-gol.199322284-93.

9 LjumanoviR,LangendijkJA,SchenkB,etal.SupraglotticcarcinomatreatedwithcurativeradiationtherapyidentificationofprognosticgroupswithMRimaging.Radiology.2004232440-8.

10 PhelpsPD.Carcinomaofthelarynxtheroleofimaginginstagingandpre-treatmentassessments.

ClinRadiol.19924677-83. 11 ZbrenP,BeckerM,LangH.Pretherapeuticstagingof laryngealcarcinoma.Clinical findings,com-

putedtomography,andmagneticresonance imagingcomparedwithhistopathology.Cancer.1996771263-73.

12 MutoM,NakaneM,KatadaC,etal.Squamouscellcarcinomainsituatoropharyngealandhypopha-ryngealmucosalsites.Cancer.20041011375-81.

13 MutoM,KatadaC,SanoY,etal.Narrowbandimaginganewdiagnosticapproachtovisualizean-giogenesisinsuperficialneoplasia.ClinGastroenterolHepatol.20053S16-20.

14 XCT199194577-86.

15 StuckensenT,KovcsAF,AdamsS,etal.StagingoftheneckinpatientswithoralcavitysquamouscellcarcinomasaprospectivecomparisonofPET,ultrasound,CTandMRI.JCraniomaxillofacSurg.200028319-24.

16 DietlB,MarienhagenJ,KhnelT,etal.FDG-PETinradiotherapytreatmentplanningofadvancedheadandneckcanceraprospectiveclinicalanalysis.AurisNasusLarynx.200633303-9.

17 GordinA,DaitzchmanM,DoweckI,etal.Fluorodeoxyglucose-positronemissiontomographycom-

putedtomographyimaginginpatientswithcarcinomaofthelarynxdiagnosticaccuracyandimpactonclinicalmanagement.Laryngoscope.2006116273-8.

18 RumboldtZ,GordonL,GordonL,etal.Imaginginheadandneckcancer.CurrTreatOptionsOncol.2006723-34.

19 KyzasPA,EvangelouE,Denaxa-KyzaD,etal.18F-fluorodeoxyglucosepositronemissiontomogra-

009592-01_GL_02_DIC95_.indd 2 17/09/25 19:31

16/181

3

phytoevaluatecervicalnodemetastasesinpatientswithheadandnecksquamouscellcarcinomaaMeta-analysis.JNatlCancerInst.2008100712-20.

20 LiaoLJ,LoWC,HsuWL,etal.DetectionofcervicallymphnodemetastasisinheadandneckcancerpatientswithclinicallyN0neck-ameta-analysiscomparingdifferentimagingmodalities.BMCCan-cer.201212236.

21 FletcherJW,DjulbegovicB,SoaresHP,etal.Recommendationsontheuseof18F-FDGPETinon-cology.JNuclMed.200849480-508.

22 200329526-40.

23 JOHNS1997131281-5.

009592-01_GL_02_DIC95_.indd 3 17/09/25 19:31

17/181

18/181

1

A

-A-1

1

TNM

009592-01_GL_03_A-01-06_DIC95_.indd 1 17/09/25 19:33

19/181

2

2

CTMRI

NBI

3

surgical site infectionSSI 1-52448

009592-01_GL_03_A-01-06_DIC95_.indd 2 17/09/25 19:33

20/181

3

4

222

5

CQ

1 CDC. Infection Control and Hospital Epidemiology Guideline for Prevention of Surgical Site Infection, 1999.

2 2013 3 42014 4 CDC. Draft Guideline for the Prevention of Surgical Site Infection, 2014. 5

2016

009592-01_GL_03_A-01-06_DIC95_.indd 3 17/09/25 19:33

21/181

4

-A-2QOL

1 1

CRT

ICTMACH-NC 154.56.52.4-1CRT 2

2

CQ11-2CQ11-1CQ12-1QOLCRT 3,4 258.6

CDDP100mgm 2

3EGFRCmab

CQ11-7-1 5CmabCRT 6

CRTRTRT

009592-01_GL_03_A-01-06_DIC95_.indd 4 17/09/25 19:33

22/181

5

3RT

chemoselection

ICTCQ11-8CRTCRPRPRPRCBDCA-RTCmab-RT

CDDP5-FUPFTXTCDDP5-FUTPF 7PFTPF 8TPFTPFCDDP-RT

CRTCRTICT-TPFCRTCRTICTCRT 9

TPF 10CQ2-6

4

CRTPFCQ12-1

2

QOLCDDPKey Drug

009592-01_GL_03_A-01-06_DIC95_.indd 5 17/09/25 19:33

23/181

6

11PF 12CDDP 100mgm 25-FU 1000mgm 2day45days370805-FUPF 13CmabCDDPPFPFPFCmabQOL 15CDDPCBDCA6coursePt5-FUCmabTPF2

6DOCPTXS-1MTXPD-1DOCMTXCmab 16 17CQ11-8immune-related adverse eventirAE 18

1 Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcionomathree meta-analysis of updated individual data. Lancet. 2000355949-55.

2 Pignon JP, Aurlie Al, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancerMACH-NCan update 93 randomized trials and 17,346 patients. Radiotherapy and Oncology. 2009924-14.

3 Lin S, Tham IW, Pan J, et al. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am J Clin Oncol. 201235474-9.

4 Chen MY, Jiang R, Guo L, et al. Locoregional radiotherapy in patients with distant metastasis of nasopharyngeal carcinoma at diagnosis. Chin J Cancer. 201332604-13.

5 Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck N Engl J Med. 200635456778.

6 Ang KK, Zhang Q, Rosenthal DI, et al. Randomized phase trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage to head and neck carcinomaRTOG 0522. J

009592-01_GL_03_A-01-06_DIC95_.indd 6 17/09/25 19:33

24/181

7

Clin Oncol. 2014322940-50. 7 Janoray G, Pointreau Y, Garaud P, et al. Long-term results of a multicenter randomized phase trial

of induction chemotherapy with cisplatin, 5-fluorouracil, -docetaxel for larynx preservation. J Natl Cancer Inst. 20151084. piidjv368.

8 Blanchard P, Bourhis J, Lacas B, et al. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancersan individual patients data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group. J Clin Oncol. 2013312854-60.

9 Budach W, Blke E, Kammers K, et al. Induction chemotherapy followed by concurrent radio-chemotherapy versus radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neckHNSCCa meta-analysis of randomized trials. Radiotherapy and Oncology. 2016118238-43.

10 Zhong L, Zhang C, Ren G, et al. Randomized phase trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma. J Clin Oncol. 201231744-51.

11 Morton RP, Rugman F, Droman EB, et al. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and necka randomised factorial phase controlled trial. Cancer chemotherapy and pharmacology. 198515283-289.

12 Kish JA, Weaver A, Jacob J, et al. Cisplatin and 5-fuluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer. 1984531819-24.

13 Gibson MK, Li Y, Murphy B, et al. Randomized Phase evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancerE1395an intergroup trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2005233562-67.

14 Vermorken J, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 20083591116-27.

15 Yoshino T, Hasegawa Y, Takahashi S, et al. Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent andor metastatic squamous cell carcinoma of the head and neckresults of a phase study trial. Jpn J Clin Oncol. 201343524-31.

16 Ferris RL, Blumenschen G, Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the

head and neck. N Engl J Med. 20163751856-67. 17 NCCN Clinical Practice Guideline in Oncology Head and Neck Cancers Version 2. 2017. httpswww.

nccn.orgprofessionalsphysician_glspdfhead-and-neck18 2017

009592-01_GL_03_A-01-06_DIC95_.indd 7 17/09/25 19:33

25/181

8

-A-3

1 4

1156,515 256.4HR0.82p0.000153.4HR0.92p0.003 3

2 intensity modulated radiotherpyIMRT

IMRT5871 IMRT Grade2 HR0.76p0.0001 4QOLIMRT 5,6IMRTIMRTQOL 7

2016IMRT

009592-01_GL_03_A-01-06_DIC95_.indd 8 17/09/25 19:33

26/181

9

3

QOL

1 Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 198827131-46.

2 Bourhis J, Overgaard J, Audry H, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancera meta-analysis. Lancet. 2006368843-54.

3 Nguyen-Tan PF, Zhang Q, Ang KK, et al. Randomized phase trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 triallong-term report of efficacy and toxicity. Journal of clinical oncologyofficial journal of the American Society of Clinical Oncology. 2014323858-66.

4 Marta GN, Silva V, de Andrade Carvalho H, et al. Intensity-modulated radiation therapy for head and neck cancersystematic review and meta-analysis. Radiotherapy and oncologyjournal of the European Society for Therapeutic Radiology and Oncology. 20141109-15.

5 Tribius S, Bergelt C. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck canceris there a worthwhile quality of life gain? Cancer treatment reviews. 201137511-9.

6 Klein J, Livergant J, Ringash J. Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapya systematic review. Oral Oncol. 201450254-62.

7 Lohia S, Rajapurkar M, Nguyen SA, et al. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014140331-7.

009592-01_GL_03_A-01-06_DIC95_.indd 9 17/09/25 19:33

27/181

10

-A-4

21

Intention to treatITT

ITT

1

Prevention

ProphylacticinterventionSymptom management2

1PreventionProphylacticintervention

2Symptommanagement

009592-01_GL_03_A-01-06_DIC95_.indd 10 17/09/25 19:33

28/181

11

1

2

1

/

11-3

009592-01_GL_03_A-01-06_DIC95_.indd 11 17/09/25 19:33

29/181

12

TPLERTND

2

Common Terminology Criteria for Adverse EventsCTCAEGradeCTCAE v4.0 JCOG

CTCAE v4.03MedDRA v12.0MedDRAJ v19.0httpwww.jcog.jpdoctortoolCTCAEv4J_20160310.pdf

CTCAE

3

1 4113

Grade40

1960Nature 5B 6C1

60Gy 7-960GyC2

009592-01_GL_03_A-01-06_DIC95_.indd 12 17/09/25 19:33

30/181

13

2

2B

3

C2

4

10

11 12B

5

13

5

009592-01_GL_03_A-01-06_DIC95_.indd 13 17/09/25 19:33

31/181

14

1 Navari RM, Qin R, Ruddy KJ, et al. Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting. The New England journal of medicine. 2016375134-42.

2 Zenda S, Matsuura K, Tachibana H, et al. Multicenter phase study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy. Radiotherapy and oncolo-gyjournal of the European Society for Therapeutic Radiology and Oncology. 2011101410-4.

3 Hofheinz RD, Deplanque G, Komatsu Y, et al. Recommendations for the Prophylactic Management of Skin Reactions Induced by Epidermal Growth Factor Receptor Inhibitors in Patients With Solid Tu-mors. The oncologist. 2016211483-91.

4 Zenda S, Ishi S, Kawashima M, et al. A Dermatitis Control ProgramDeCoPfor head and neck can-cer patients receiving radiotherapya prospective phase study. International journal of clinical oncology. 201318350-5.

5 Winter GD. Formation of the scab and the rate of epithelization of superficial wounds in the skin of the young domestic pig. Nature. 1962193293-4.

6 Zenda S, Ishi S, Akimoto T, et al. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapya retrospective analysis. Jap-anese journal of clinical oncology. 201545433-8.

7 Bostrom A, Lindman H, Swartling C, et al. Potent corticosteroid creammometasone furoatesignifi-cantly reduces acute radiation dermatitisresults from a double-blind, randomized study. Radiother-apy and oncologyjournal of the European Society for Therapeutic Radiology and Oncology. 200159257-65.

8 Shukla PN, Gairola M, Mohanti BK, et al. Prophylactic beclomethasone spray to the skin during post-operative radiotherapy of carcinoma breasta prospective randomized study. Indian journal of can-cer 200643180-4.

9 Miller RC, Schwartz DJ, Sloan JA, et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapya phase double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. International journal of radiation oncology, biology, physics, 2011791460-6.

10 Elting LS, Cooksley C, Chambers M, et al. The burdens of cancer therapy. Clinical and economic out-comes of chemotherapy-induced mucositis. Cancer. 2003981531-9.

11 Nabil S, Samman N. Risk factors for osteoradionecrosis after head and neck radiationa systematic review. Oral surgery, oral medicine, oral pathology and oral radiology. 201211354-69.

12 Yokota T, Tachibana H, Konishi T, et al. Multicenter phase study of an oral care program for pa-tients with head and neck cancer receiving chemoradiotherapy. Supportive care in cancerofficial journal of the Multinational Association of Supportive Care in Cancer. 2016243029-36.

13 20162016

009592-01_GL_03_A-01-06_DIC95_.indd 14 17/09/25 19:33

32/181

15

-A-5

1 1

41 1,2

23

20138 3

9CQ1ABC1

32010

CAREER 4

2 1

009592-01_GL_03_A-01-06_DIC95_.indd 15 17/09/25 19:33

33/181

16

/

WHO2002WHO

Demands)QOL

1 12

1ClinicalQuestionClinicalQuestion

1 ADLQOL B

2 B

3 B

4 C1

5 B

6 C1

7 B

8 A

9 B

10 B

3

009592-01_GL_03_A-01-06_DIC95_.indd 16 17/09/25 19:33

34/181

17

dump and swallow

5

2

7VFVE

OEPEG

PAPPLP

VFVE

009592-01_GL_03_A-01-06_DIC95_.indd 17 17/09/25 19:33

35/181

18

36482

VF9 6

536 7PAP3PAP 8

3 1

5

21

009592-01_GL_03_A-01-06_DIC95_.indd 18 17/09/25 19:33

36/181

19

voice prosthesisVega TMAtos Medicalvoice prosthesis2

75

3 91

85255316

6QOLQOL 10

52173 1120377 12

voice prosthesisvoice prosthesisProvox 2 TM59062.8 13109066.7 14

4 1

QOL

009592-01_GL_03_A-01-06_DIC95_.indd 19 17/09/25 19:33

37/181

20

QOL

QOL 15

2

VFVE1

ST

3VF

VF 16

2VF32 17

3

009592-01_GL_03_A-01-06_DIC95_.indd 20 17/09/25 19:33

38/181

21

18

5 1radical neck dissectionRND

modified radical neck dissectionMRNDselective radical neck dissectionSND1 5

2

range of motionROM

RNDMRNDSND

33

153036 19

31015 20

456150 21

009592-01_GL_03_A-01-06_DIC95_.indd 21 17/09/25 19:33

39/181

22

1 2011pp23-37

2 Dietz JH. Rehabilitation oncology, John Wiley Sons, New York, USA, 1981 3

2013. 4 CAREERhttpwww.lpc.or.jpreha2015430 5

2011pp68-87. 6 Dejonckere PH, Hordijk GJ. Prognostic factors for swallowing after treatment of head and neck

cancer. Clin Otolaryngol Allied Sci. 199823218-23. 7 Suarez-Cunqueiro MM, Schramm A, Schoen R, et al. Speech and swallowing impairment after

treatment for oral and oropharyngeal cancer. Arch Otolaryngol Head Neck Surg. 20081341299-304.

8 de Carvalho-Teles V, Sennes LU, Gielow I. Speech evaluation after palatal augmentation in patients undergoing glossectomy. Arch Otolaryngol Head Neck Surg. 20081341066-70.

9 Hillman RE, Walsh MJ, Wolf GT, et al. Functional outcomes following treatment for advanced laryngeal cancer. Part --Voice preservation in advanced laryngeal cancer. Part --Laryngectomy rehabilitationthe state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl. 19981721-27.

10 Finizia C, Bergman B. Health-related quality of life in patients with laryngeal cancera post-treatment comparison of different modes of communication. Laryngoscope. 2001111918-23.

11 Hybasek I. Surgical substitution of glottis after total laryngectomy. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 198124325-9.

12 Mehta AR, Sarkar S, Mehta SA, et al. The Indian experience with immediate tracheoesophageal puncture for voice restoration. Eur Arch Otorhinolaryngol. 1995252209-14.

13 Terada T, Saeki N, Toh K, et al. Voice rehabilitation with Provox2 voice prosthesis following total laryngectomy for laryngeal and hypopharyngeal carcinoma. Auris Nasus Larynx. 20073465-71.

14 Voice prosthesis20096016-22.

15 FRONTIER2015346-9

16 Lazarus CL, Logemann JA, Pauloski BR, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 19961061157-66.

17 Bleier BS, Levine MS, Mick R, et al. Dysphagia after chemoradiationanalysis by modified barium swallow. Ann Otol Rhinol Laryngol. 2007116837-41.

18 Nguyen NP, Moltz CC, Frank C, et alDysphagia following chemoradiation for locally advanced head and neck cancer. Ann Oncol. 200415383-8.

19 Salerno G, Cavaliere M, Foglia A, et alThe 11 th nerve syndrome in functional neck dissection. Laryngoscope. 20021121299-307.

20 McNeely ML, Parliament MB, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivorsa randomized controlled trial. Cancer. 2008113214-22.

21 20083467-70.

009592-01_GL_03_A-01-06_DIC95_.indd 22 17/09/25 19:33

40/181

23

-A-6

1 20

WHO

sufferingQuality of Life 1

WHO91 1

Quality of DeathQOLSuffering

QOL 2

1

QOL

1

009592-01_GL_03_A-01-06_DIC95_.indd 23 17/09/25 19:33

41/181

24

3

2

12007

20082017393,250

2

21107-102107-103456789

1132second-line PD

4

009592-01_GL_03_A-01-06_DIC95_.indd 24 17/09/25 19:33

42/181

25

201533306,500102 4

3 3

3

1 World Health Organization. Definition of palliative care. GenevaWHO, 2002. www.who.intcancerpalliativedefinitionen. last accessed Apr.29, 2017.

2 Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010363733-42.

3 Yoong J, Park ER, Greer JA, et al. Early palliative care in advanced lung cancera qualitative study. JAMA Intern Med. 2013173283-90.

4 Hui D, Mori M, Watanabe SM, et al. Referral criteria for outpatient specialty palliative cancer carean international consensus. Lancet Oncol. 201617e552-9.

009592-01_GL_03_A-01-06_DIC95_.indd 25 17/09/25 19:33

43/181

44/181

-B-11

B

-B-1

1 T

TX T0 Tis T1 2cm5mm

T2 2cm5mm10mm2cm4cm10mm

T3 4cm10mmT4a

T4a

T4b

T4a

N

NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

009592-01_GL_03_B-01-09_DIC95_.indd 1 17/09/25 19:34

45/181

2

N3a6cmN3b

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0A T4a N0N1 M0 T1T2T3T4a N2 M0B T N3 M0 T4b N M0C T N M1

009592-01_GL_03_B-01-09_DIC95_.indd 2 17/09/25 19:34

46/181

-B-13

2

T1T2

N0

N

T3

N0

N

T4

N0

N

CQ11-4

T1T2T31-4CQ2-1

5-10CQ2-2CQ2-311,12CQ2-4

009592-01_GL_03_B-01-09_DIC95_.indd 3 17/09/25 19:34

47/181

4

CQ2-6

1 NakagawaT,ShibuyaH,YoshimuraR,etal.Necknodemetastasisaftersuccessfulbrachytherapyforearlystagetonguecarcinoma.RadiotherOncol.200368129-35.

2 OotaS,ShibuyaH,YoshimuraR,etal.Brachytherapyofstagemobiletonguecarcinoma.PredictionoflocalcontrolandQOL.RadiatOncol.2006121.

3 200247741-9

4 InoueTa,InoueTo,YoshidaK,etal.Phasetrialofhigh-vs.low-dose-rateinterstitialradiotherapyforearlymobiletonguecancer.IntJRadiatOncolBiolPhys.200151171-5.

5 274200430550-7

6 200531536-40

7 20041473-9

8 124200496317-22 9 T2-T4N0200248

Suppl.1S25-32 10 LimSC,ZhangS,IshiiG,etal.Predictivemarkersforlatecervicalmetastasisinstageandinva-

sivesquamouscellcarcinomaoftheoraltongue.ClinCancerRes.2004101Pt1166-72. 11 KimataY,UchiyamaK,EbiharaS,etal.Postoperativecomplicationsandfunctionalresultsaftertotal

glossectomywithmicrovascularreconstruction.PlastReconstrSurg.20001061028-35.12

19866964-72

009592-01_GL_03_B-01-09_DIC95_.indd 4 17/09/25 19:34

48/181

-B-25

-B-2

1 T

TX T0 Tis T1 T2

T3

T4a

T4b

V2

N

NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c 6cmN3a 6cmN3b

009592-01_GL_03_B-01-09_DIC95_.indd 5 17/09/25 19:34

49/181

6

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0A T1T2T3 N2 M0 T4a N0N1N2 M0B T4b N M0 T N3 M0C T N M1

009592-01_GL_03_B-01-09_DIC95_.indd 6 17/09/25 19:34

50/181

-B-27

2

T1

N0

N

T2

N0

N

T3

N0

N

T4a

N0

N

6070Gy303567

1-56intensitymodulatedradiotherapyIMRTCQ11-5

009592-01_GL_03_B-01-09_DIC95_.indd 7 17/09/25 19:34

51/181

8

CQ3-17-910

CQ3-2

1 199194214-24

2 200349145-7 3 DulguerovP,JacobsenMS,AllalAS,etal.Nasalandparanasalsinuscarcinomaarewemaking

progress Aseriesof220patientsandasystematicreview.Cancer.2001923012-29. 4 200147233-5 5 NibuK,SugasawaM,AsaiM,etal.Resultsofmultimodalitytherapyforsquamouscellcarcinomaof

maxillarysinus.Cancer.2002941476-82. 6 KawashimaM,OginoT,HayashiR,etal. Influenceofpostsurgicalresidual tumorvolumeon local

controlinradiotherapyformaxillarysinuscancer.JpnJClinOncol.200131195-202. 7 19711786-99 8 SatoY,MoritaM,TakahashiHO,etal.Combinedsurgery,radiotherapy,andregionalchemotherapy

incarcinomaoftheparanasalsinuses.Cancer.197025571-9. 9 ItamiJ,UnoT,ArugaM,etal.Squamouscellcarcinomaofthemaxillarysinustreatedwithradiation

therapyandconservativesurgery.Cancer.199882104-7. 10

200127142-7

009592-01_GL_03_B-01-09_DIC95_.indd 8 17/09/25 19:34

52/181

-B-39

-B-3

1 T

TX T0 Tis T1

T2

T3 T4

N

NX N0 N1

6cmN2 6cmN3 6cm

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T1 N1 M0

009592-01_GL_03_B-01-09_DIC95_.indd 9 17/09/25 19:34

53/181

10

T2 N0N1 M0 T1T2 N2 M0 T3 N0N1N2 M0A T4 N0N1N2 M0A T N3 M0B T N M1

2

T1, N0, M0Stage

T1T2, N23, M0T34, N03, M0StageA

T1, N1, M0T2, N01, M0Stage

2

2

1

3

1

3

3

1 CQ4-1CQ4-3CQ4-4

2

3 CQ4-1CQ4-4

4 CQ4-2

CQ12-2

-A

4050Gy

6070Gy303567CT

009592-01_GL_03_B-01-09_DIC95_.indd 10 17/09/25 19:34

54/181

-B-311

IMRT1,2CTMRIPETPET-CT

3-7CQ4-14

8

1 PowEH,KwongDL,McMillanAS,etal.Xerostomiaandqualityoflifeafterintensity-modulatedra-diotherapyvs.conventionalradiotherapyforearly-stagenasopharyngealcarcinomainitialreportonarandomizedcontrolledclinicaltrial.IntJRadiatOncolBiolPhys.200666981-91.

2 KamMK,LeungSF,ZeeB,etal.Prospectiverandomizedstudyofintensity-modulatedradiotherapyonsalivaryglandfunctioninearly-stagenasopharyngealcarcinomapatients.JClinOncol.2007254873-9.

3 LangendijkJA,LeemansCR,ButerJ,etal.Theadditionalvalueofchemotherapytoradiotherapyinlocallyadvancednasopharyngealcarcinomaameta-analysisofthepublishedliterature.JClinOncol.2004224604-12.

4 BaujatB,AudryH,BourhisJ,etal.Chemotherapyinlocallyadvancednasopharyngealcarcinomaanindividualpatientdatameta-analysisofeightrandomizedtrialsand1753patients.IntJRadiatOn-colBiolPhys.20066447-56.

5 ZhangL,ZhaoC,GhimireB,etal.Theroleofconcurrentchemoradiotherapyinthetreatmentoflo-coregionallyadvancednasopharyngealcarcinomaamongendemicpopulationameta-analysisofthephaserandomizedtrials.BMCCancer.201010558.

6 ChenL,HuCS,ChenXZ,etal.Concurrentchemoradiotherapyplusadjuvantchemotherapyversusconcurrentchemoradiotherapyaloneinpatientswithlocoregionallyadvancednasopharyngealcarci-nomaaphase3multicentrerandomisedcontrolledtrial.LancetOncol.201213163-71.

7 ChenQY,WenYF,GuoL,etal.Concurrentchemoradiotherapyvsradiotherapyaloneinstagena-

sopharyngealcarcinomaphaserandomizedtrial.JNatlCancerInst.20111031761-70. 8 WeiWI.Cancerofthenasopharynxfunctionalsurgicalsalvage.WorldJSurg.200327844-8.

009592-01_GL_03_B-01-09_DIC95_.indd 11 17/09/25 19:34

55/181

12

-B-4

1 T

p16TX T0 Tis T1 2cmT2 2cm4cmT3 4cmT4a /

T4b

p16TX T0 Tis T1 2cmT2 2cm4cmT3 4cmT4 /

009592-01_GL_03_B-01-09_DIC95_.indd 12 17/09/25 19:34

56/181

-B-413

N

p16NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

N3a 6cmN3b

p16NX N0 N1 6cmN2 6cmN3 6cm

M

M0 M1

p160 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0

009592-01_GL_03_B-01-09_DIC95_.indd 13 17/09/25 19:34

57/181

14

A T1T2T3 N2 M0 T4a N0N1N2 M0B T4b N M0 T N3 M0C T N M1p16

0 Tis N0 M0 T1T2 N0N1 M0 T1T2 N2 M0 T3 N0N1N2 M0 T1T2T3 N3 M0 T4 N M0 T N M1

2

T1

N0

N

TN

T

N

009592-01_GL_03_B-01-09_DIC95_.indd 14 17/09/25 19:34

58/181

-B-415

T2

N0

N

TN

T

N

T

N

T3T4

N0

N

TN

1HPVHPV1,2TNMUICC/AJCC82017HPVp16HPVp16HPVN

HPVp16HPV3,4

009592-01_GL_03_B-01-09_DIC95_.indd 15 17/09/25 19:34

59/181

16

CQ5-1

4050Gy

6070Gy3035675HPV6,7

T12

8HPV3,4pull throughlevel9,1011

HPV3,4

1 AngKK,HarrisJ,WheelerR,etal.Humanpapillomavirusandsurvivalofpatientswithoropharyn-gealcancer.NEnglJMed.201036324-35.

2 HorneZD,GlaserSM,VargoJA,etal.Confirmationofproposedhumanpapillomavirusrisk-adaptedstagingaccording toAJCCUICCTNMcriteria forpositiveoropharyngeal carcinomas.Cancer.2016122132021-30.

3 MastersonL,MoualedD,LiuZW,etal.De-escalationtreatmentprotocols forhumanpapillomavi-rus-associatedoropharyngealsquamouscellcarcinomaasystematicreviewandmeta-analysisofcurrentclinicaltrials.EurJCancer.2014502636-48.

4 MirghaniH,AmenF,BlanchardP,etal.Treatmentde-escalation inHPV-positiveoropharyngealcarcinomaongoingtrials,criticalissuesandperspectives.IntJCancer.13671494-503,2015

009592-01_GL_03_B-01-09_DIC95_.indd 16 17/09/25 19:34

60/181

-B-417

5 PignonJP,BourhisJ,DomengeC,etal.Chemotherapyaddedtolocoregionaltreatmentforheadand

necksquamous-cellcarcinomathreemeta-analysesofupdatedindividualdata.Lancet2000355949-55.

6 BernierJ,CooperJS,PajakTF,etal.Definingrisk levels in locallyadvancedheadandneckcan-cersacomparativeanalysisofconcurrentpostoperativeradiationpluschemotherapytrialsof theEORTC#22931andRTOG#9501.HeadNeck.200527843-50.

7 CooperJS,PajakTF,ForastiereAA,etalRadiationTherapyOncologyGroup9501Intergroup.Postoperativeconcurrentradiotherapyandchemotherapyforhigh-risksquamous-cellcarcinomaoftheheadandneck.NEnglJMed.20043501937-44.

8 AdelsteinDJ,RidgeJA,BrizelDM,etal.TransoralresectionofpharyngealcancerSummaryofaNationalCancerInstituteHeadandNeckCancerSteeringCommitteeClinicalTrialsPlanningMeet-ing,November6-7,2011,Arlington,Virginia.HeadNeck.2012341681-703

9 10-712pp220-62000 b

10 LimYC,KooBS,LeeJS,etal.Distributionsofcervicallymphnodemetastasesinoropharyngealcarci-nomatherapeuticimplicationsfortheN0neck.Laryngoscope.20061161148-52. b

11 KimataY,UchiyamaK,SakurabaM,etal.Velopharyngeal functionaftermicrosurgicalreconstruc-tionoflateralandsuperiororopharyngealdefects.Laryngoscope.20021121037-42.

009592-01_GL_03_B-01-09_DIC95_.indd 17 17/09/25 19:34

61/181

18

-B-5

1 T

TX T0 Tis T1 12cmT2 1

2cm4cmT3 4cmT4a

T4b

N

NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

N3a 6cmN3b

009592-01_GL_03_B-01-09_DIC95_.indd 18 17/09/25 19:34

62/181

-B-519

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0A T1T2T3 N2 M0 T4a N0N1N2 M0B T4b N M0 T N3 M0C T N M1

2

T1

N0

N

009592-01_GL_03_B-01-09_DIC95_.indd 19 17/09/25 19:34

63/181

20

T2

N0

N

T3

p.

T4a

p.

009592-01_GL_03_B-01-09_DIC95_.indd 20 17/09/25 19:34

64/181

-B-521

CQ11-4

CQ6-1CQ6-2QOL

6070Gy303567

T121,23,4

5-910-1213-1516

009592-01_GL_03_B-01-09_DIC95_.indd 21 17/09/25 19:34

65/181

22

17-20CQ11-13

1 VandenbrouckC,EschwegeF,DelaRochefordiereA,etal.Squamouscellcarcinomaofthepyriformsinusretrospectivestudyof351casesattheInstitutGustave-Roussy.HeadNeckSurg.1987104-13.

2 GardenAS,MorisonWH,ClaymanGL,etal.Earlysquamouscellcarcinomaofthehypopharynxoutcomesoftreatmentwithradiationalonetotheprimarydisease.HeadNeck.199618317-22.

3

1999104-10. 4 PignonJP,BourhisJ,DomengeC,etal.Chemotherapyaddedtolocoregionaltreatmentforheadand

neck squamous-cell carcinomathreemeta-analyses of updated individual data.MACH-NCCollaborativeGroup.Meta-AnalysisofChemotherapyonHeadandNeckCancer.Lancet.2000355949-55.

5 NakatsukaT,HariiK,UedaK,etal.Preservationofthelarynxafterresectionofacarcinomaoftheposteriorwallofthehypopharynxversatilityofafreeflappatchgraft.HeadNeck.199719137-42.

6 LaccourreyeO,Mrite-DrancyA,BrasnuD, et al. Supracricoidhemilaryngopharyngectomy inselectedpyriformsinuscarcinomastagedasT2.Laryngoscope.19931031373-9.

7 NakayamaM,TakahashiH,YaoK,etal.Limitedsurgeryforcancerofthelarynxandhypopharynxoptionsandconsequences.ActaOtolaryngolSuppl.200254741-5.

8 JOHNS1999151227-9. 9 -1996501975-83. 10 TimonCV,TonerM,ConlonBJ.Paratracheal lymphnode involvement inadvancedcancerof the

larynx,hypopharynx,andcervicalesophagus.Laryngoscope.20031131595-9. 11 SpauldingCA,HahnSS,ConstableWC.Theeffectivenessoftreatmentoflymphnodesincancersof

thepyriformsinusandsupraglottis.IntJRadiatOncolBiolPhys.198713963-8. 12 BillersHF,DavisWH,Ogura JH.Delayedcontralateral cervicalmetastaseswith laryngeal and

laryngopharyngealcancers.Laryngoscope.1971811499-502. 13 MutoM,NakaneM,KatadaC, et al. Squamous cell carcinoma in situ at oropharyngeal and

hypopharyngealmucosalsites.Cancer.20041011375-81. 14 MutoM,KatadaC,SanoY,etal.Narrowband imaginganewdiagnosticapproach tovisualize

angiogenesisinsuperficialneoplasia.ClinGastroenterolHepatol.20053S16-20. 15 -ELPS

2006109581-6. 16 ShiotaniA,TomifujiM,ArakiK,etal.Videolaryngoscopictransoralenblocresectionofsupraglottic

andhypopharyngealcancersusing laparoscopicsurgical instruments.AnnOtolRhinolLaryngol.2010119225-32.

17 Lefebvre JL,ChevalierD,LuboinskiB, et al. Larynxpreservation inpyriformsinus cancerpreliminaryresultsofaEuropeanOrganizationforResearchandTreatmentofCancerphasetrial.EORTCHeadandNeckCancerCooperativeGroup.JNatlCancerInst.199688890-9.

18 BeauvillianC,MahM,BourdinS,etal.Finalresultsofarandomizedtrialcomparingchemotherapyplusradiotherapywithchemotherapyplussurgeryplusradiotherapyinlocallyadvancedresectablehypopharyngealcarcinomas.Laryngoscope.1997107648-53.

009592-01_GL_03_B-01-09_DIC95_.indd 22 17/09/25 19:34

66/181

-B-523

19 TheDepartmentofVeteransAffairsLaryngealCancerStudyGroup. Inductionchemotherapyplusradiationcomparedwithsurgeryplusradiationinpatientswithadvancedlaryngealcancer.NEnglMed.19913241685-90.

20 BonnerJA,HarariPM,GiraltJ,etal.Radiotherapypluscetuximabforsquamous-cellcarcinomaoftheheadandneck.NEnglJMed.2006354567-78.

009592-01_GL_03_B-01-09_DIC95_.indd 23 17/09/25 19:34

67/181

24

-B-6

1 T

TX T0 Tis

T1 1T2 2

T3

T4a

T4b

T1

T1a T1b

T2

T3

T4a

T4b

009592-01_GL_03_B-01-09_DIC95_.indd 24 17/09/25 19:34

68/181

-B-625

T1 T2 T3 T4a

T4b

N

NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

N3a 6cmN3b

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0

009592-01_GL_03_B-01-09_DIC95_.indd 25 17/09/25 19:34

69/181

26

A T4a N0N1 M0 T1T2T3T4a N2 M0B T4b N M0 T N3 M0C T N M1

2

Tis

T

N

T1

N0

N

1

1

1

1

1

TN

009592-01_GL_03_B-01-09_DIC95_.indd 26 17/09/25 19:34

70/181

-B-627

T

N

T2

N0

N

1

1

1

1

TN

1

T3

N0

N

1

1

T4a, N03

009592-01_GL_03_B-01-09_DIC95_.indd 27 17/09/25 19:34

71/181

28

1

2CQ11-4

1CQ7-1

X46MV3

212Gy5T160

66Gy3033T270Gy352-42T21

56

78

009592-01_GL_03_B-01-09_DIC95_.indd 28 17/09/25 19:34

72/181

-B-629

9-11CQ7-112-18CQ7-2T4a19,2021-23

CQ11-3

1 PfisterDG,LaurieSA,WeinsteainGS,etal.AmericanSocietyofClinicalOncologyclinicalpracticeguideline fortheuseof larynx-preservationstrategies inthetreatmentof laryngealcancer.JClinOncol.2006243693-704.

2 201642016113-8.

3 MendenhallWM,ParisonJT,StringerSP,etal.T1-T2vocalcordcarcinomaabasisforcomparingtheresultsofradiotherapyandsurgery.HeadNeckSurg198810373-7.

4 InoueT,InoueT,IkedaH,etal.Prognosticfactoroftelecobalttherapyforearlyglottiscarcinoma.Cancer.1992702797-801.

5 ForastiereAA,GopfertH,MaorMH,etal.Concurrentchemotherapyandradiotherapy fororganpreservationinadvancedlaryngealcancer.NEnglJMed.20033492091-8.

6 PignonJP,MaitreA,maillardE,etal.Meta-analysisofchemotherapyinheadandneckMACH-NCAnupdateon93randomizedtrialsand17,346patients.RadiotherOncol.2009924-14.

7 WardMC,AdelsteinDJ,BhatejaP,etal.SeverelatedysphagiaandcauseofdeathafterconcurrentchemoradiationforlarynxcancerinpatientseligibleforRTOG91-11.OralOncol.20165721-26.

8 ForastiereAA,ZhangQ,WeberRS,etal.Long-TermResultsofRTOG91-11AComparisonof

ThreeNonsurgicalTreatmentStrategiestoPreservetheLarynxinPatientswithLocallyAdvancedLarynxCancer.JClinOncol.201331845-52.

9 MendenhallWM,Werning JW,HinermanRW,et al.ManagementofT1-T2glottic carcinomas.Cancer.20041001786-92. b

10 CohenSM,GarrettCG,DupontWDetal.Voice-relatedqualityoflifeinT1glotticcancerirradia-tionversusendoscopicexcision.AnnOtolRhinollaryngol.2006115581-6.

11 OsbornHA,HuA,VenkatatesanV,etal.Comparisonofendoscopiclaserresectionversusradiationtherapyforthetreatmentofearlyglottiscarcinoma.JOtolaryngolHeadNeckSurg.201140200-4.

b12 HolsingerFC,NussenbaumB,NakayamaM,etal.Currentconceptsandnewhorizonsinconserva-

tionlaryngealsurgeryanimportantpartofmultidisciplinarycare.HeadNeck.201032656-65. 13 SteinerW,VogtP,AmbroschP,etal.Transoralcarbondioxide lasermicrosurgery forrecurrent

glotticcarcinomaafterradiotherapy.HeadNeck.200426477-84. 14 AnserinM,PlanickaM,RotundoS,etal.Endoscopiccarbondioxidelasersurgeryforglottiscancer

recurrenceafterradiotherapy.ArchOtolaryngolHeadNeckSurg.20071331193-7.

009592-01_GL_03_B-01-09_DIC95_.indd 29 17/09/25 19:34

73/181

30

15 200632355-9. 16 74

2007110571-80. 17 NakayamaM,OkamotoM,HayakawaK,etal.Clinicaloutcomeofsupracricoid laryngectomywith

cricohyoidepiglottopexyradiationfailureversuspreviouslyuntreatedpatients.AurisNasusLarynx.201340207-10. b

18 MakeieffM,VenegoniD,MercanteG,etal.Supracricoidpartiallaryngectomiesafterfailureofradia-tiontherapy.Laryngoscope.2005115353-7.

19 GregoireVLefebvreJL,LicitraL.etal.Squamouscellcarcinomaof theheadandneckEHNSESMOESTROClinicalPracticeGuidelinesfordiagnosis,treatmentandfollow-up.AnnOncol.201021184-6.

20 NCCNClinicalPracticeGuidelinesinOncologyNCCNGuidelinesHeadandNeckCancerVersion2.2016

httpwww.nccn.orgprofessionalsphysician_glspdfhead-and-neck.pdf21 SpauldingCA,HahnSS,ConstableWC.Theeffectivenessoftreatmentoflymphnodesincancersof

thepyriformsinusandsupraglottis.IntJRadiatOncolBiolPhys.198713963-8. 22 BillersHF,DavisWH,Ogura JH.Delayedcontralateral cervicalmetastaseswith laryngeal and

laryngopharyngealcancers.Laryngoscope.1971811499-502. 23 1995585-94.

009592-01_GL_03_B-01-09_DIC95_.indd 30 17/09/25 19:34

74/181

-B-731

-B-7

1 papillarythyroidcarcinomaPTCfollicularthy-

roidcarcinomaFTCmedullarythyroidcarcinomaMTCundif-ferentiatedanaplasticthyroidcarcinomaATCdifferentiatedthyroidcarcinomaDTC

71UICCTNM72016UICC8220181

T

TX T0 T1 2cm

T1a1cmT1b1cm2cm

T2 2cm4cmT3 4cm

T3a 4cmT3b strapmuscles

T4a

T4b

Hurthle

N

NX N0 N1

009592-01_GL_03_B-01-09_DIC95_.indd 31 17/09/25 19:34

75/181

32

N1aDel-phian

N1b

55

T N M0 T N M155

T1aT1bT2 N0 M0 T3 N0 M0 T1T2T3 N1 M0 T4a N M0A T4b N M0B T N M1

T1aT1b N0 M0 T2T3 N0 M0 T1T2T3 N1a M0A T1T2T3 N1b M0 T4a N M0B T4b N M0C T N M1

A T1T2T3a N0 M0B T1T2T3a N1 M0B T3bT4aT4b N0N1 M0C T N M1Hurthle

2

11979

EORTC LaheyClinicAMESAge,Metastasis,Extrathyroidal invasion,

009592-01_GL_03_B-01-09_DIC95_.indd 32 17/09/25 19:34

76/181

-B-733

Size MayoClinic AGESAge,Grade,Extent,Size MACISMetastasis,Age,Completenessofresection,Invasion,Size3-6

2009ATA78ATA20159

2ATA-DTC20151

50.2cm

53cm

3cm4

009592-01_GL_03_B-01-09_DIC95_.indd 33 17/09/25 19:34

77/181

34

3

T1

N0

N1b

N1a

T2T3

N0

N1b

N1a

T4

N0

N1b

N1a

ATAN1b

9

radioactive iodineRAI2010131 I30mCi2012

recombinantTSHrhTSH131 IRAI600mCiRAI

RAIATA-DTC2015NCCN

009592-01_GL_03_B-01-09_DIC95_.indd 34 17/09/25 19:34

78/181

-B-735

20164cm0.2cm59,10

RAICQ8-3

N011,12, 1314CQ8-2

shaving15

RAI

131 I9

CQ8-4

131 IRAIRAI131 I100200mCi10

16,176

TSHTSH

McGriff18SugitaniRCTTSH

009592-01_GL_03_B-01-09_DIC95_.indd 35 17/09/25 19:34

79/181

36

TSH19

NCCNTSH0.1mULTSH0.10.5mUL10TSH0.5Uml20

RAItyrosinekinase inhibitor

TKI21-23PFSOSQOLCQ8-5

CEA

MEN2AMEN2BRET24

6category1102015CQ8-5

5cm

StageAB6,10,25ATCTKI26CQ8-5

1 72015 2 AJCCCancerStagingManualEighthEditionSpringer2016 3 SandersLE,CadyB.Differentiatedthyroidcancerreexaminationofriskgroupsandoutcomeof

treatment.ArchSurg.1998133419-25. 4 HayID,GrantCS,TaylorWF,McConaheyWM.Ipsilaterallobectomyversusbilaterallobarresection

009592-01_GL_03_B-01-09_DIC95_.indd 36 17/09/25 19:34

80/181

-B-737

inpapillarythyroidcarcinomaaretrospectiveanalysisofsurgicaloutcomeusinganovelprognosticscoringsystem.Surgery.19871021088-95.

5 DeanDS,HayID.Prognosticindicatorsindifferentiatedthyroidcarcinoma.CancerControl.20007229-39.

6 20102010

7 AmericanThyroidAssociationATAGuidelinesTaskforceonThyroidNodulesandDifferentiatedThyroidCancer.CooperDS,DohertyGM,HaugenBR,etal.RevisedAmericanThyroidAssociationmanagementguidelinesforpatientswiththyroidnodulesanddifferentiatedthyroidcancer.Thyroid.2009191167-214.

8 TuttleRM,TalaH,ShahJ,etal.EstimatingriskofrecurrenceindifferentiatedthyroidcanceraftertotalthyroidectomyandradioactiveiodineremnantablationusingresponsetotherapyvariablestomodifytheinitialriskestimatespredictedbythenewAmericanThyroidAssociationstagingsystem.Thyroid.2010201341-9.

9 HaugenBR,AlexanderEK,BibleKC,etal.2015AmericanSocietyofThyroidAssociationManage-mentGuidelines forAdultPatientswithThyroidNodulesandDifferentiatedThyroidCancer.Thy-roid.2016261-92.

10 NCCNClinicalPracticeGuidelinesInOncologyHeadandNeckCancers. httpwww.nccn.orgprofessionalsphysician_glspdfhead-and-neck.pdf 11 -1996581375. 12 SugitaniI,FujimotoY,YamadaK,etal.Prospectiveoutcomesofselectivelymphnodedissectionfor

papillarythyroidcarcinomabasedonpreoperativeultrasonography.WorldJSurg.2008322494-502.

13 ItoY,MiyauchiA.Laterallymphnodedissectionguidedbypreoperativeandintraoperativefindingsindifferentiatedthyroidcarcinoma.WorldJSurg.200832729-39.

14 ErbilY,BarbarosU,IseverH,etal.Predictivefactorsforrecurrentlaryngealnervepalsyandhypo-parathyroidismafterthyroidsurgery.ClinOtolaryngol.20073232-7.

15 CzajaJM,McCaffreyTV.Thesurgicalmanagementoflaryngotrachealinvasionbywell-differentiat-edpapillarythyroidcarcinoma.ArchOtolaryngolHeadNeckSurg.19971235484-90.

16 DuranteC,HaddyN,BaudinE,etal.Long-termoutcomeof444patientswithdistantmetastasesfrompapillaryandfollicularthyroidcarcinomabenefitsandlimitsofradioiodinetherapy.JClinEn-docrinolMetab.2006912892-9.

17 SchlumbergerM,ChalletonC,DeVathaireF,etal.Radioactiveiodinetreatmentandexternalradio-therapyforlungandbonemetastasesfromthyroidcarcinoma.JNuclMed.199637598-605.

18 McGriffNJ,CsakoG,GourgiotisL,etal.Effectsofthyroidhormonesuppressiontherapyonadverse

clinicaloutcomesinthyroidcancer.AnnMed.200234554-64. 19 Sugitani I,FujimotoY.Doespostoperativethyrotropinsuppressiontherapytrulydecreaserecur-

rence inpapillary thyroidcarcinoma Arandomizedcontrolled trial. JClinEndocrinolMetab.2010954576-83.

20 SurksMI,OrtizE,DanielsGH,etal.Subclinicalthyroiddiseasescientificreviewandguidelinesfordiagnosisandmanagement.JAMA.2004291228-38.

21 BroseMS,NuttingCM,JarzabB,etal.Sorafenibinradioactiveiodine-refractory,locallyadvancedormetastaticdifferentiatedthyroidcancerarandomised,double-blind,phase3 trial.Lancet.2014384319-28.

22 SchlumbergerM,TaharaM,WirthLJ,etal.Lenvatinibversusplacebo inradio-iodine-refractorythyroidcancer.NEngJMed.2015372621-30.

23 KiyotaN,SchlumbergerM,MuroK,etal.SubgroupanalysisofJapanesepatientsinaphase3studyoflenvatinibinradioiodine-refractorydifferentiatedthyroidcancer.CancerSci.20151061714-21.

24 WellsSAJr,AsaSL,DralleH,etal.RevicedAmericanThyroidAssociationGuidelinesfortheMan-

009592-01_GL_03_B-01-09_DIC95_.indd 37 17/09/25 19:34

81/181

38

agementofMedullaryThyroidCarcinoma.Thyroid.201525567-610. 25 SmallridgeRC,AinKB,AsaSL,etal.AmericanThyroidAssociationGuidelinesforManagementof

PatientswithAnaplasticThyroidCancer.Thyroid.2012221104-39. 26 TaharaM,KiyotaN,YamazakiT,etal.LenvatinibforAnaplasticThyroidCancer.Frontiers in

Oncology.201725343-4.

009592-01_GL_03_B-01-09_DIC95_.indd 38 17/09/25 19:34

82/181

-B-839

-B-8

1 T

TX T0 T1 2cmT2 2cm4cmT3 4cmT4a T4b

T4aT4b

N

NX N0 N1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

N3a 6cmN3b

009592-01_GL_03_B-01-09_DIC95_.indd 39 17/09/25 19:34

83/181

40

M

M0 M1

0 Tis N0 M0 T1 N0 M0 T2 N0 M0 T3 N0 M0 T1T2T3 N1 M0A T1T2T3 N2 M0 T4a N0N1N2 M0B T4b N M0 T N3 M0C T N M1

2 585MucoepidermoidcarcinomalowgradeAciniccellcar-cinomaPolymorphousadenocarcinomaClearcellcarcinomaBasalcelladenocarcinomaIntraductalcarcinomaNOSAdenocarcinomaNOSlowgradeEpithelial-myoepithelialcarcino-maCarcinomaexpleomorphicadenomaintracap-sularandminimallyinvasivetypesSecretorycarcinomaOnco-cyticcarcinomaSialoblastoma55085MucoepidermoidcarcinomaintermediategradeAdenoidcysticcarcinomacribriformandtubulartypesSebaceousadenocarcinomaLymphoepithelialcarcinoma550MucoepidermoidcarcinomahighgradeAde-noidcysticcarcinomasolidtype NOS Adenocarcinoma,NOShighgradeSalivaryductcarcinomaMyoepithelialcarcinomaCarcinomaexpleomorphicadenomawidely invasivetypeCarcinosarcomaPoorlydifferentiatedcarcinomaSquamouscellcarcinoma

009592-01_GL_03_B-01-09_DIC95_.indd 40 17/09/25 19:34

84/181

-B-841

3

T1T2

N0

N

T3T4

N0

N

QOL

CQ9-21,23CQ9-1

4-6

1 GuntinasLichiusO,KlussmannJP,SchroederU,etal.Primaryparotidmalignomasurgeryinpa-tientswithnormalpreoperativefacialnervefunctionoutcomeandlongtermpostoperativefacialnervefunction.Laryngoscope.2004114949-56.

2 GodballeC,SchultzJH,KrogdahlA,etal.Parotidcarcinomaimpactofclinicalfactorsonprognosisinahistologicallyrevisedseries.Laryngoscope.20031131411-7.

3 SpiroRH.Managementofmalignanttumorsofthesalivaryglands.OncologyWillistonPark.1998

009592-01_GL_03_B-01-09_DIC95_.indd 41 17/09/25 19:34

85/181

42

12671-80discussion683. 4 GardenAS,WeberRS,MorrisonWH,etal.Theinfluenceofpositivemarginsandnerveinvasionin

adenoidcysticcarcinomaoftheheadandnecktreatedwithsurgeryandradiation.IntJRadiatOncolBiolPhys.199532619-26.

5 KoulR,DubeyA,ButlerJ,etal.Prognosticfactorsdepictingdiseasespecificsurvivalinparotidglandtumors.IntJRadiatOncolBiolPhys.200768714-8.

6 SpiroJD,SpiroRH.Canceroftheparotidglandroleof7 thnervepreservation.WorldJSurg.200327863-7.

009592-01_GL_03_B-01-09_DIC95_.indd 42 17/09/25 19:34

86/181

-B-943

-B-92017UICCTNM8

p16HPVEBVp16EBERinsituhybridizationHPVEBV351,2

FNACFNAC1

1 T

T0

N

NcNN1 3cmN2

N2a3cm6cm

N2b6cmN2c6cm

N3a 6cmN3b

009592-01_GL_03_B-01-09_DIC95_.indd 43 17/09/25 19:34

87/181

44

NpNpN1 3cmpN2

pN2a3cm3cm6cm

pN2b6cmpN2c6cm

pN3a 6cmpN3b 3cm

M

M0 M1

T0 N1 M0A T0 N2 M0B T0 N3 M0C T0 N1N2N3 M1

2

1,213

narrowbandimagingNBI451

CTMRICTMRI1

009592-01_GL_03_B-01-09_DIC95_.indd 44 17/09/25 19:34

88/181

-B-945

6PETPETCTPET30PETCT505mm1,7

108

50701,2

N

21,23cm9-

6570Gy50Gy6064Gy21,2,9CDDP10

1 SchmalbachCE,MillerFR.Occultprimaryheadandneckcarcinoma.CurrentOncologyreport.20079139-46.

2 PavlidisN,PentheroudakisG,PlataniotisG.Cervicallymphnodemetastasesofsquamouscellcarcino-mafromanunknownprimarysiteafavourableprognosissubsetofpatientswithCUP.ClinTranslOncol.200911340-8.

3 Jereczek-FossaBA,JassemJ,OrecchiaR.Cervicallymphnodemetastasesofsquamouscellcarcino-mafromanunknownprimary.CancerTreatRev.200430153-64.

4 ShinozakiT,HayashiR,EbiharaM,etal.Narrowbandimagingendoscopyforunknownprimarytu-morsitesoftheneck.HeadNeck2012.34826-9.

5 SakaiA,OkamiK,EbisumotoK,etal.Newtechniques todetectunknownprimaries incervicallymphnodemetastasis.Laryngoscope.20101201779-83.

6 LewJI,RodgersSEA,SolorzanoCC.Developmentsintheuseofultrasoundforthyroidcancer.CurrOpinOncol.20102211-6.

7 MillerFR,HusseyD,BeeramM,etal.Positronemissiontomographyinthemanagementofunknownprimaryheadandneckcarcinoma.ArchOtolaryngolHeadNeckSurg.2005131626-9.

009592-01_GL_03_B-01-09_DIC95_.indd 45 17/09/25 19:34

89/181

46

8 KochWM,BhattiN,WilliamsMF,etal.Oncologicrationale forbilateral tonsillectomy inheadandnecksquamouscell carcinomaofunknownprimarysource.OtolaryngolHeadNeckSurg.2001124331-3.

9 StrojanP,FerlitoA,LanqendijkJA,etal.Contemporarymanagementof lymphnodemetastasesfromanunknownprimarytotheneck.Areviewoftherapeuticoptions.HeadNeck.201335286-93.

10 ShehadehNJ,EnsleyJF,KucukO,etal.Benefitofpostoperativechemoradiotherapyforpatientswithunknownprimarysquamouscellcarcinomaoftheheadandneck.HeadNeck.2006281090-8.

009592-01_GL_03_B-01-09_DIC95_.indd 46 17/09/25 19:34

90/181

-11

-1CQ

11 NCT

B N CT

N

1,2CTMRI1CT

CTMRI2-4MRICT5PETPET-CT2

1 CurtinHD,IshwaranH,MancusoAA,etal.ComparisonofCTandMRimaginginstagingofneckmetastases.Radiology.1998207123-30.

2 Kyzas PA,EvangelouE,Denaxa-KyzaD, et al. 18F-Fluorodeoxyglucose positron emissiontomography toevaluatecervicalnodemetastases inpatientswithheadandnecksquamouscellcarcinomaameta-analysis.JNatlCancerInst.2008100712-20.

3 KingAD,TseGM,AhujaAT,etal.NecrosisinmetastaticnecknodesdiagnosticaccuracyofCT,MRimagingandUS.Radiology.2004230720-26.

4 KingAD,TseGM,YuenEH,etal.ComparisonofCTandMRimagingforthedetectionofextranodalneoplasticspreadinmetastaticnecknodes.EurJRadiol.200452264-70.

5 SomPM.Detectionofmetastasis incervical lymphnodesCTandMRcriteriaanddifferentialdiagnosis.AJRAmJRoentogenol.1992158961-9.

PubMedCTnecknodalstage52CTnecknodalstaging106

CTnecknodemetastasis338CTN

MRnecknodemetastasis44PETnecknodemetastasis171

32

009592-01_GL_04_01-05_DIC95_.indd 1 17/09/25 19:35

91/181

2

CQ12 TMRI

B T MRI

TMRICT

MRI

MRICT12TMRI1,2MRICT3,4MRICTMRIT5CTTMRI5CTMRI6MRI

1 NgSH,ChanSC,YenTC,etal.StagingofuntreatednasopharyngealcarcinomawithPETCTcomparisonwithconventionalwork-up.EurJNuclMedMolImaging.20093612-22.

2 KingAD,VlantisAC,BhatiaKS,etal.PrimarynasopharyngealcarcinomadiagnosticaccuracyofMRimagingversusthatofendoscopyandendoscopicbiopsy.Radiology.2011258531-7.

3 LeslieA,FyfeE,Guest P, et al. Staging of squamous cell carcinoma of the oral cavity and

oropharynxacomparisonofMRIandCTinT-andN-Staging.JComputAssistTomogr.19992343-9.

4 BolzoniA,CappielloJ,PiazzaC,etal.Diagnosticaccuracyofmagneticresonance imaging in theassessment ofmandibular involvement in oral-oropharyngeal squamous cell carcinomaaprospectivestudy.ArchOtolaryngolHeadNeckSurg.2004130837-43.

5 ZbrenP,BeckerM,LngH.Pretherapeuticstagingofhypopharyngealcarcinoma.Clinicalfindings,computedtomorgraphy,andmagneticresonanceimagingcomparedwithhistopathologicevaluation.ArchOtolaryngolHeadNeckSurg.1997123908-13.

6 ZbrenP,BeckerM,LngH.Stagingof laryngealcancerendoscopy,computedtomographyandmagneticresonanceversushistopathology.EurArchOtorhinolaryngol.1997254S117-22.

PubMed headandneckcancerstageMR 80nasopharyngealcarcinoma

MR104nasopharyngealcarcinomaCT403oralcavitycarcinoma

stagingMR32oralcavitycarcinomaimaging859oropharyngeal

009592-01_GL_04_01-05_DIC95_.indd 2 17/09/25 19:35

92/181

-13

carcinomastagingMR 19laryngealcancerstagingMR 28

hypopharygealcarcinomastagingimaging78

CQ13

B US

1US2CT3MRIFDG-PETPET-CT4US

US5,6US1,5,7US831US5,6USUS18US

US1,2,4, 55055vs70802CT3US

1 ParkJS,SonKR,NaDG,etal.Performanceofpreoperativesonographicstagingofpapillarythyroidcarcinomabasedonthesixtheditionof theAJCCUICCTNMclassificationsystem.AJR.200919266-72.

2 KouvarakiMA,ShapiroSE,FornageBD,etal.Roleofpreoperativeultrasonographyinthesurgicalmanagementofpatientswiththyroidcancer.Surgery.2003134946-54.

3 AhnJE,LeeJH,YiJS,etal.DiagnosticaccuracyofCTandultrasonographyforevaluatingmetastatic

cervicallymphnodesinpatientswiththyroidcancer.WorldJSurg.2008321552-8. 4 ChoiWH,ChungYA,HanEJ,etal.Clinicalvalueof integrated18Ffluoro-2-deoxyD-glucose

positronemissiontomographycomputedtomography in thepreoperativeassessmentofpapillarythyroidcarcinomacomparisonwithsonography.JUltrasoundMed.2011301267-73.

5 LewJI,RodgersSE,SolorzanoCC.Developmentsintheuseofultrasoundforthyroidcancer.Curr

OpinOncol.20102211-6. 6 2010p.35-39.

009592-01_GL_04_01-05_DIC95_.indd 3 17/09/25 19:35

93/181

4

7 SowerbyL,Franklin JH,ChinCJ, et al.Discrepancybetweenultrasoundand final pathologicmeasurementsinthyroidcancer.JOtolaryngolHeadNeckSurg.201140453-7.

8 TomodaC,UrunoT,TakamuraY,etal.Ultrasonographyasamethodof screening for trachealinvasionbypapillarythyroidcancer.SurgToday.200535819-22.

PubMedthyroidcancerstagingultrasonography67

2010

CQ14

B

fineneedleaspirationcytologyFNAC

FNACFNACFNAC194.296.985.598.498.479.760752,32

FNAC904,5US6FNAC57,89FNAC3,6-9FNAC

1 TandonS,ShahabR,BentonJI,etal.Fine-needleaspirationcytology inaregionalheadandneckcancercentercomparisonwithasystematicreviewandmeta-analysis.HeadNeck.2008301246-52.

2 CohenEG,PatelSG,LinO,etal.Fine-needleaspirationbiopsyofsalivaryglandlesionsinaselectedpatientpopulation.ArchOtolaryngolHeadNeckSurg.2004130773-8.

009592-01_GL_04_01-05_DIC95_.indd 4 17/09/25 19:35

94/181

-15

3 LinAC,BhattacharyyaN.Theutilityof fineneedleaspiration inparotidmalignancy.OtolaryngolHeadNeckSurg.2007136793-8.

4 SeiberlingKA,DutraJC,GunnJ,etal.Ultrasound-guided fineneedleaspirationbiopsyof thyroidnodulesperformedintheoffice.Laryngoscope.2008118228-31.

5 2010pp43-4492-932010.

6 MoonHJ,KwakJY,KimEK,etal.Thecombinedroleofultrasoundandfrozensection insurgicalmanagementof thyroidnodulesreadassuspicious forpapillarythyroidcarcinomaon fineneedleaspirationbiopsyaretrospectivestudy.WorldJSurg.200933950-57.

7 NishimuraG,MatsudaH,TaguchiT,etal.Treatmentevaluationofmetastatic lymphnodesafterconcurrentchemoradiotherapyinpatientswithheadandnecksquamouscellcarcinoma.AnticancerRes.201232595-600.

8 YomSS,GardenAS,StaerkelGA, et al. Sonographic examination of theneck afterdefinitiveradiotherapyfornode-positiveoropharyngealcancer.AJNRAmJNeuroradiol.2011321532-8.

9 AtulaTS,VarpulaMJ,KurkiTJ,etal.Assessmentofcervicallymphnodestatusinheadandneck

cancerpatientspalpation, computed tomography and low fieldmagnetic resonance imagingcomparedwithultrasound-guidedfine-needleaspirationcytology.EurJRadiol.199725152-61.

PubMedheadandneckcancerFNAC363

CQ15

A

1889Billroth1932WarrenGates

IARCIACR

6,2212

756514.5,481.914.1,2.62,000232

009592-01_GL_04_01-05_DIC95_.indd 5 17/09/25 19:35

95/181

6

38.9218.717.0639.19253.0231.2216.087.106.5822.36

4,56

1 200632292-9.

2 200329526-540

3 --1993961501-9

4 PetitT,GeorgesC,JungGM,etal.Systematicesophagealendoscopyscreeninginpatientspreviouslytreatedforheadandnecksquamous-cellcarcinoma.AnnOncol.200112643-6.

5 ChungCS,LoWC,WenMH,etal.LongTermOutcomeofRoutineImage-enhancedEndoscopyinNewlyDiagnosedHeadandNeckCanceraProspectiveStudyof145Patients.SciRep.2016629573.

6 YamamotoE,ShibuyaH,YoshimuraR,etal.Sitespecificdependencyofsecondprimarycancerinearlystageheadandnecksquamouscellcarcinoma.Cancer2002942007-14.

3216

PubMedheadandneccancer,endoscopyscreening,survivalrate632

retoroprosupectivestudy

CQ16 FDG-PET

BPET NM

PETFDG-PET

F-18

009592-01_GL_04_01-05_DIC95_.indd 6 17/09/25 19:35

96/181

-17

GaPET-CT

PETNPETKyzas17995 CI72858695 CI8389cN08795 CI76935095 CI3763Liao2cN0PETCTMRIMPET103

PETPET252

PETFDGPETPET7310057100CTMRI388783

1 Kyzas PA, EvangelouE,Denaxa-KyzaD, et al. 18 F-fluorodeoxyglucose positron emissiontomography toevaluatecervicalnodemetastases inpatientswithheadandnecksquamouscellcarcinomaameta-analysis.JNatlCancerInst.2008100712-20.

2 LiaoLJ,LoWC,HsuWL,etal.Detectionofcervicallymphnodemetastasisinheadandneckcancerpatientswith clinicallyN0neck-ameta-analysis comparingdifferent imagingmodalities.BMCCancer.201212236.

3 FletcherJW,DjulbegovicB,SoaresHP,etal.Recommendationson theuseof18F-FDGPET inoncology.JNuclMed.200849480-508.

PubMedheadandneckneoplasmsheadneckcancerPET

8023

3

009592-01_GL_04_01-05_DIC95_.indd 7 17/09/25 19:35

97/181

8

CQ17

BCTMRI

B PET-CT

12

34Schwartzintensive5Kissum5449220918MRI11CT614526

1990X2000CT2000PET-CTXVisscherX7OMearaX8WarnerXCTCTX9NCCNCT10CTMRI3611NCCN10

PET-CTCTMRI12,133

009592-01_GL_04_01-05_DIC95_.indd 8 17/09/25 19:35

98/181

-19

RTCRTNCCNCRT48CTPET812CT

20126OngCRTPETPET-CT1214IslesPET-CTCRT101520153PET-NECKstudy12PET-CT16

CTMRI

CTXCT

22CTMRI17

PET-CT

1 SimoR,HomerJ,ClarkeP, etal.Follow-upafter treatment forheadandneckcancerUnitedKingdomNationalMultidisciplinaryGuidelines.JLaryngolOtol.2016130S208-S211.

2 ManikantanK,KhodeS,DwivediRC,etal.Makingsenseofpost-treatmentsurveillanceinheadandneckcancerwhenandwhatoffollow-up.CancerTreatRev.200935744-53.

3 ManikantanK,DwivediRC,SayedSI,etal.Currentconceptsofsurveillanceanditssignificanceinheadandneckcancer.AnnRCollSurgEngl.201193576-82.

4 FlynnCJ,KhaouamN,GardnerS, et al.Thevalue of periodic follow-up in thedetection ofrecurrencesafterradical treatment in locallyadvancedheadandneckcancer.ClinOncolRCollRadiol.201022868-73.

5 SchwartzDL,BarkerJJr,ChanskyK,etal.Postradiotherapysurveillancepracticeforheadandnecksquamouscellcarcinoma--toomuchfortoolittle?HeadNeck.200325990-9.

6 KissunD,MagennisP,LoweD,etal.Timingandpresentationofrecurrentoralandoropharyngealsquamouscellcarcinomaandawareness intheoutpatientclinic.BrJOralMaxillofacSurg.200644371-6.

7 deVisscherAV,ManniJJ.Routinelong-termfollow-upinpatientstreatedwithcurativeintentforsquamous cell carcinomaof the larynx, pharynx, and oral cavity.Does itmake sense?ArchOtolaryngolHeadNeckSurg.1994120934-9.

8 OMearaWP,Thiringer JK, JohnstonePA.Follow-upofheadandneck cancerpatientspost-radiotherapy.RadiotherOncol.200366323-6.

9 WarnerGC,CoxGJ.Evaluationofchestradiographyversuschestcomputedtomographyinscreening

009592-01_GL_04_01-05_DIC95_.indd 9 17/09/25 19:35

99/181

10

forpulmonarymalignancyinadvancedheadandneckcancer.JOtolaryngol.200332107-9. 10 RomanBR,GoldenbergD,GiviB.EducationCommitteeofAmericanHeadandNeckSocietyAHNS..

AHNSSeries--Doyouknowyourguidelines?Guidelinerecommendedfollow-upandsurveillanceofheadandneckcancersurvivors.HeadNeck.201638168-74.

11 HermansR, PameijerFA,MancusoAA, et al. Laryngeal or hypopharyngeal squamous cellcarcinomacanfollow-upCTafterdefinitiveradiationtherapybeusedtodetectlocalfailureearlierthanclinicalexaminationalone?Radiology.2000214683-7.

12 YooJ,HendersonS,Walker-DilksC.Evidence-basedguideline recommendationson theuseofpositronemissiontomographyimaging inheadandneckcancer.ClinOncolRCollRadiol.201325e33-66.

13 FletcherJW,DjulbegovicB,SoaresHP,etal.Recommendationson theuseof18F-FDGPET inoncology.JNuclMed.200849480-508.

14 OngSC,SchderH,LeeNY,etal.Clinicalutilityof18F-FDGPETCTinassessingtheneckafterconcurrentchemoradiotherapyforLocoregionaladvancedheadandneckcancer.JNuclMed.200849532-40.

15 IslesMG,McConkeyC,MehannaHM.Asystematicreviewandmeta-analysisoftheroleofpositronemission tomography in the followup of head and neck squamous cell carcinoma followingradiotherapyorchemoradiotherapy.ClinOtolaryngol.200833210-22.

16 MehannaH,WongWL,McConkeyCC, et al.PET-CTSurveillanceversusNeckDissection inAdvancedHeadandNeckCancer.NEnglJMed.2016374151444-54.

17 LoeffelbeinDJ,EiberM,MayrP,etal.Loco-regionalrecurrenceaftersurgical treatmentoforalsquamouscellcarcinomaProposals for follow-up imagingbasedon literature,nationalguidelinesandinstitutionalexperience.JCraniomaxillofacSurg.2015431546-52.

PubMedrecurrence,imaging,recommendations,headandneckcancer

5266

1

CQ18

C1

A

B

1SCCCYFRA21-13060

009592-01_GL_04_01-05_DIC95_.indd 10 17/09/25 19:35

100/181

-111

C1

2,3A

16414654B

1 GuerraEN,RgoDF,EliasST,etal.Diagnosticaccuracyofserumbiomarkers forheadandneckcancerAsystematicreviewandmeta-analysis.CritRevOncolHematol.201610193-118.

2 GiovanellaL,TregliaG,SadeghiR,etal.Unstimulatedhighlysensitivethyroglobulininfollow-upof

differentiatedthyroidcancerpatientsameta-analysis.JClinEndocrinolMetab.201499440-7 3 Eustatia-Rutten CF, Smit JW, Romijn JA, et al. Diagnostic value of serum thyroglobulin

measurementsinthefollow-upofdifferentiatedthyroidcarcinoma,astructuredmeta-analysis.ClinEndocrinolOxf.20046161-74.

4 BoomsmaMJ,BijlHP,LangendijkJA.Radiation-inducedhypothyroidism inheadandneckcancerpatientsasystematicreview.RadiotherOncol.20119915.

serumbiomarkerheadandneckcancermeta-analysis16thyroidneoplasmthyro-

globulinfollowupmeta-analysis13hypothyroidismheadandneckcancerirradia-

tion490CQ4

009592-01_GL_04_01-05_DIC95_.indd 11 17/09/25 19:35

101/181

12

-2CQ

21

B MRIUS CT

2018TNM8

depthofinvasionDOIT5mmDOI10mmT2DOI10mmT3113,149DOITheInternationalConsortiumforOutcomeResearchICORinHeadandNeckCancer1

2

DOICTMRIDOIthicknessDOI4mm6mmDOI

depth

thickness2depththickness

depththicknessMRI3-11depth5,97,112DOIDOI

USShintani1213-16YesuratnamUSMRIUSthickness16USthicknessDOI

CTMRICT

009592-01_GL_04_01-05_DIC95_.indd 12 17/09/25 19:35

102/181

-213

CTthickness17

AlsaffarMRIdepth45mmMRIdepth5mmdepth

depththicknessLwin0.70.8610Goel0.85cT3pT2depththicknessDOI

1 InternationalConsortiumforOutcomeResearchICORinHeadandNeckCancer,EbrahimiA,GilZ,etal.Primary tumorstaging fororalcancerandaproposedmodification incorporatingdepthofinvasionan internationalmulticenter retrospective study. JAMAOtolaryngolHeadNeckSurg.20141401138-48.

2 AminMB,EdgeSB,GreeneFL,etal.AJCCCancerStagingManual8thed.,Springer,NewYork2017

3 ImaiT,SatohI,MatsumotoK,etal.Retrospectiveobservationalstudyofoccultcervicallymph-nodemetastasis inT1N0tonguecancer.JpnJClinOncol.2016Nov25.EpubaheadofprintPubMedPMID27889695.

4 AlsaffarHA,GoldsteinDP,KingEV,etal.CorrelationbetweenclinicalandMRIassessmentofdepthofinvasioninoraltonguesquamouscellcarcinoma.JOtolaryngolHeadNeckSurg.20164561.

5 GoelV,PariharPS,PariharA,etal.AccuracyofMRIinPredictionofTumourThicknessandNodal

StageinOralTongueandGingivobuccalCancerWithClinicalCorrelationandStaging.JClinDiagnRes.201610TC01-5.

6 LamP,Au-YeungKM,ChengPW,etal.CorrelatingMRIandhistologic tumor thickness in theassessmentoforaltonguecancer.AJRAmJRoentgenol.2004182803-8.

7 PredaL,ChiesaF,CalabreseL,etal.RelationshipbetweenhistologicthicknessoftonguecarcinomaandthicknessestimatedfrompreoperativeMRI.EurRadiol.2006162242-8.

8 ParkJO,JungSL,JooYH,etal.Diagnosticaccuracyofmagneticresonance imagingMRIintheassessmentoftumorinvasiondepthinoraloropharyngealcancer.OralOncol.201147381-6.

9 JungJ,ChoNH,KimJ,etal.Significantinvasiondepthofearlyoraltonguecanceroriginatedfrom

the lateralbordertopredictregionalmetastasesandprognosis. IntJOralMaxillofacSurg.200938653-60.

10 LwinCT,HanlonR,LoweD,etal.AccuracyofMRI inpredictionof tumourthicknessandnodalstageinoralsquamouscellcarcinoma.OralOncol.201248149-54.

11 IwaiH,KyomotoR,Ha-KawaSK,etal.Magneticresonancedeterminationof tumorthicknessas

009592-01_GL_04_01-05_DIC95_.indd 13 17/09/25 19:35

103/181

14

predictivefactorofcervicalmetastasisinoraltonguecarcinoma.Laryngoscope.2002112457-61. 12 ShintaniS,NakayamaB,MatsuuraH,etal. Intraoralultrasonography isuseful toevaluatetumor

thicknessintonguecarcinoma.AmJSurg.1997173345-7. 13 MarkTaylor S,DroverC,MaceachernR, et al. Is preoperativeultrasonography accurate in

measuringtumorthicknessandpredictingtheincidenceofcervicalmetastasis inoralcancer?OralOncol.20104638-41.

14 YuenAP,NgRW,LamPK,etal.Preoperativemeasurementof tumor thicknessoforal tonguecarcinomawithintraoralultrasonography.HeadNeck.200830230-4.

15 LodderWL,TeertstraHJ,Tan IB, et al.Tumour thickness in oral cancerusingan intra-oralultrasoundprobe.EurRadiol.20112198-106.

16 YesuratnamA,WiesenfeldD,TsuiA,etal.Preoperativeevaluationoforal tonguesquamouscellcarcinomawith intraoral ultrasound andmagnetic resonance imaging-comparison withhistopathological tumour thickness and accuracy in guiding patientmanagement. Int JOralMaxillofacSurg.201443787-94.

17 Madana J, LalibertF,MorandGB, et al. Computerized tomographybased tumor-thicknessmeasurementisusefultopredictpostoperativepathologicaltumorthicknessinoraltonguesquamouscellcarcinoma.JOtolaryngolHeadNeckSurg.20154449.

PubMedoraltongue,thickness,depth,measurement,magneticresonanceimaging

151

CQ22

C1

lowdoserateLDRhighdoserateHDRLDR192Ir137Cs198AuHDR192Irremoteafter-loadingsystemRALS

T1N0T2N01-5T36,74,6

799372801-5,81,2,45819675891-5,8

009592-01_GL_04_01-05_DIC95_.indd 14 17/09/25 19:35

104/181

-215

LDRHDR7-935

1,4,1010QOL11

1 ShibuyaH,HoshinaM,TakedaM,etal.Brachytherapyforstageoraltonguecancerananalysisofpastcasesfocusingoncontrolandcomplications.IntJRadiationOncolBiolPhys.19932651-8.

2 IchimiyaY,FuwaN,KamataM,etal.TreatmentresultsofstageIoraltonguecancerwithdefinitive

radiotherapy.OralOncol.200541520-5. 3 -

113456-622010. 4 FujitaM,HirokawaY,KashiwadoK,etal.InterstitialbrachytherapyforStageandsquamous

cellcarcinomaoftheoraltonguefactorsinfluencinglocalcontrolandsofttissuecomplications.IntJRadiationOncolBiolPhys.199944767-75.

5 UmedaM,KomatsubaraH,OjimaY,etal.Acomparisonofbrachytherapyandsurgery for thetreatmentofstage-squamouscellcarcinomaofthetongue.IntJOralMaxillofacSurg.200534739-44.

6 IharaN,ShibuyaH,YoshimuraR,etal.InterstitialbrachytherapyandneckdissectionforStagesquamouscellcarcinomaofthemobiletongue.ActaOncol.200544709-16.

7 KakimotoN,InoueT,InoueT,etal.Resultsoflow-andhigh-dose-rateinterstitialbrachytherapyforT3mobiletonguecancer.RadiotherOncol.200368123-8.

8 InoueT,InoueT,ToshidaK,etal.Phasetrialofhigh-vs.low-dose-rateinterstitialradiotherapyforearlymobiletonguecancer.IntJRadiationOncolBiolPhys.200151171-5.

9 AkiyamaH,YoshidaK,ShimizutaniK,etal.Dosereductiontrialfrom60Gyin10fractionsto54Gyin9 fractionsschedule inhigh-dose-rate interstitialbrachytherapy forearlyoral tonguecancer.JRadiatRes.201253722-6.

10 MiuraM,TakedaM,SasakiT,etal.Factorsaffectingmandibularcomplications in lowdoseratebrachytherapyfororaltonguecarcinomawithspecialreferencetospacer.IntJRadiationOncolBiolPhys.199841763-70.

11 YoshimuraR,ShibuyaH,MiuraM,etal.Qualityof lifeoforalcancerpatientsafter low-dose-rateinterstitialbrachytherapy.IntJRadiationOncolBiolPhys.200973772-8.

72PubMed

interstitialradiotherapybrachytherapytonguecancer128

009592-01_GL_04_01-05_DIC95_.indd 15 17/09/25 19:35

105/181

16

CQ23

C1

20151

N0

702-45-7level9108-10

11,12N0

UMIN000006510199613

14-18Paleri200530119Thompson201326766949620

FDA2014NCCN2017T1-2N021

1 DCruzAK,VaishR,KapreN,etal.ElectiveversusTherapeuticNeckDissectioninNode-Negative

009592-01_GL_04_01-05_DIC95_.indd 16 17/09/25 19:35

106/181

-217

OralCancer.NEnglJMed.2015373521-529. 2 SchiefkeF,AkdemirM,WeberA,etal.,Function,postoperativemorbidity,andqualityof lifeafter

cervicalsentinelnodebiopsyandafterselectiveneckdissection.HeadNeck.200931503-12. 3 MurerK,HuberGF,HaileSR,etal.Comparisonofmorbiditybetweensentinelnodebiopsyand

electiveneckdissectionfortreatmentofthen0neckinpatientswithoralsquamouscellcarcinoma.HeadNeck.2011331260-4.

4 HernandoJ,VillarrealP,Alvarez-MarcosF,etal.Comparisonofrelatedcomplicationssentinelnodebiopsyversuselectiveneckdissection.IntJOralMaxillofacSurg.2014431307-12.

5 Govers,TM,TakesRP,BarisKarakullukcuM,etal.ManagementoftheN0neckinearlystageoralsquamouscellcanceramodelingstudyofthecost-effectiveness.OralOncol.201349771-7.

6 Kosuda,S,KusanoS,KohnoN, et al.Feasibilityandcost-effectivenessof sentinel lymphnode

radiolocalizationinstageN0headandneckcancer.ArchOtolaryngolHeadNeckSurg.20031291105-9.

7 OConnorR,PezierT,SchillingC,etal.Therelativecostofsentinellymphnodebiopsyinearlyoralcancer.JCraniomaxillofacSurg.201341721-7.

8 Shah, JP.Patterns of cervical lymphnodemetastasis fromsquamous carcinomasof theupperaerodigestivetract.AmJSurg.1990160405-9.

9 Byers,RM,WeberRS,AndrewsT,etal.Frequencyandtherapeuticimplicationsofskipmetastasesintheneckfromsquamouscarcinomaoftheoraltongue.HeadNeck.19971914-9.

10 Crean,SJ,HoffmanA,Potts J, et al.Reductionof occultmetastaticdiseasebyextensionof thesupraomohyoidneckdissectiontoincludelevel.HeadNeck.200325758-62.

11 Fan,SF,ZengZY,PengHW,etal.Sentinel lymphnodebiopsyversuselectiveneckdissection inpatientswithcT1-2N0oraltonguesquamouscellcarcinoma.OralSurgOralMedOralPatholOralRadiol.2014117186-90.

12 AlvarezJ,BidagurenA,McGurkM,etal.Sentinelnodebiopsyinrelationtosurvivalinfloorofthemouthcarcinoma.IntJOralMaxillofacSurg.201443269-73.

13 AlexJC,KragDN.Thegamma-probe-guidedresectionofradiolabeledprimarylymphnodes.SurgOncolClinNAm.1996533-41.

14 AlkureishiLW,RossGL,ShoaibT, et al. Sentinelnodebiopsy inheadandnecksquamouscellcancer5-yearfollow-upofaEuropeanmulticentertrial.AnnSurgOncol.2010172459-64.

15 CivantosFJ,ZitschRP,SchullerDE,etal.Sentinellymphnodebiopsyaccuratelystagestheregional

lymphnodes forT1-T2oralsquamouscellcarcinomasresultsofaprospectivemulti-institutionaltrial.JClinOncol.2010281395-400.

16 SchillingC,StoeckliSJ,HaerleSK,etal.SentinelEuropeanNodeTrialSENT3-yearresultsofsentinelnodebiopsyinoralcancer.EurJCancer.2015512777-84.

17 MiuraK,HirakawaH,UemuraH, et al. Sentinel nodebiopsy for oral cancerAprospectivemulticenterPhasetrial.AurisNasusLarynx.201744319-26.

18 FlachGB,BloemenaE,KlopWM,etal.SentinellymphnodebiopsyinclinicallyN0T1-T2stagedoralcancertheDutchmulticentertrial.OralOncol.2014501020-4.

19 PaleriV,ReesG,ArullendranP,etal.Sentinelnodebiopsyinsquamouscellcanceroftheoralcavityandoralpharynxadiagnosticmeta-analysis.HeadNeck.200527739-47.

20 ThompsonCF,StJohnMA,LawsonG,etal.Diagnosticvalueofsentinellymphnodebiopsyinheadandneckcancerameta-analysis.EurArchOtorhinolaryngol.20132702115-22.

21 AdelsteinD,GillisonML,PfisterDG,etal.NCCNGuidelines InsightsHeadandNeckCancers,Version2.2017.JNatlComprCancNetw.201715761-70.

009592-01_GL_04_01-05_DIC95_.indd 17 17/09/25 19:35

107/181

18

PubMedsentinel,lymphnodebiopsy,earlyoralcancer77

7multicenter,sentinel,headandneck382

12

CQ24

C1

8638decisionanalysis1168682201543-6N0CQ40.5795 CI0.36-0.8974

20155TATA8596380.067.53mmN320CQ

1 SongT,BiN,GuiL, at al.ElectiveneckdissectionorwatchfulwaitingoptimalmanagementstrategyforearlystageN0tonguecarcinomausingdecisionanalysistechniques.ChinMedJ.2008

009592-01_GL_04_01-05_DIC95_.indd 18 17/09/25 19:35

108/181

-219

1211871-4. V 2 KanekoS,YoshimuraT,IkemuraK,etal.Primaryneckmanagementamongpatientswithcancerof

theoralcavitywithoutclinicalnodalmetastasesadecisionandsensitivityanalysis.HeadNeck.200224582-90. V

3 VandenbrouckC,Sancho-GarnierH,ChassagneD,etal.Electiveversus therapeuticradicalneckdissectioninepidermoidcarcinomaoftheoralcavityresultsofarandomizedclinicaltrial.Cancer.198046386-90.

4 FakihAR,RaoRS,BorgesAM,etal.Electiveversustherapeuticneckdissectioninearlycarcinomaoftheoraltongue.AmJSurgery.1989158309-13.

5 KligermanJ,LimaRA,SoaresJR,etal.Supraomohyoidneckdissection inthetreatmentofT1T2squamouscellcarcinomaoforalcavity.AmJSurg.1994168391-4.

6 YuenAP,HoCM,ChowTL,etal.ProspectiverandomizedstudyofselectiveneckdissectionversusobservationforN0neckofearlytonguecarcinoma.HeadNeck.200931765-72.

7 FasunlaAJ,GreeneB,TimmesfeldN,etal.Ameta-analysisoftherandomizedcontrolledtrialsonelectiveneckdissectionversustherapeuticneckdissectioninoralcavitycancerswithclinicallynode-negativeneck.OralOncology.201147320-4.

8 DCruzAK,VanishR,KapreN,etal.Electiveversustherapeuticneckdissection innode-negativeoralcancer.NEnglJMed.2015373521-9.

PubMedtonguecancerdissectionclinical trial

36hit52

18

CQ25 N1

C2Supraomohyoid Neck DissectionSOHND N0 N SOHNDN1ExtendedSOHND

SupraomohyoidNeckDissectionSOHND

1modifiedRadicalNeckDissectionSOHND2N0SOHNDNSOHNDNSOHNDretrospectivestudyrandom-izedcontrolledtrial

Beyers27715.83Shah501

009592-01_GL_04_01-05_DIC95_.indd 19 17/09/25 19:35

109/181

20

516retrospective1.5Beyers4DiasT1T23391.56.5N01.5N23.725

AndersenN106N158-63.2588.156.74.3N6Kowalski00.6N1SOHND7,8

ShahN15164Dias9N0SOHNDNKoerdtEx-tendedSOHND10

NSOHND5Liang5retro-spectivestudyN--1112N1ExtendedSOHND

KowalskiN157.4pN07USPET-CTN1

1 FerlitoA,SomPM,RinaldoA, et al.Classificationand terminologyofneckdissections.ORLJOtorhinolaryngolRelatSpec.200062212-6.

2 BrazilianHeadandNeckCancerStudyGroup.ResultsofaProspectiveTrialonElectiveModifiedRadicalClassicalVersusSupraomohyoidNeckDissection in theManagementofOralSquamousCarcinoma.AmJSurg.1998176422-7.

3 ByersRM,WeberRS,AndrewsT, et al. Frequency andTherapeutic Implications ofSkipMetastasesintheNeckfromSquamousCarcinomaoftheOralTongue.HeadNeck.19971914-9.

009592-01_GL_04_01-05_DIC95_.indd 20 17/09/25 19:35

110/181

-221

4 ShahJP,CandelaFC,PoddarAK.ThePatternsofCervicalLymphNodeMetastasesfromSquamous

CarcinomaoftheOralCavity.Cancer.199066109-13, 5 DiasFL,LimaRA,KligermanJ,etal.Relevanceofskipmetastasesforsquamouscellcarcinomaof

theoraltongueandthefloorofthemouth.OtolaryngolHeadNeckSurg.2006134460-5. 6 AndersenPE,WarrenF,SpriroJ,etal.Resultsofselectiveneckdissection inmanagementof the

node-positiveneck.ArchOtolaryngolHeadNeckSurg.20021281180-4. 7 KowalskiLP,CarvalhoAL.FeasibilityofsupraomohyoidneckdissectioninN1andN2aoralcancer

patients.HeadNeck.200224921-4. 8

200531536-540. 9 N1

200935370-373. 10 KoerdtS,Rckl J,RommelN,etal.Lymphnodemanagement in the treatmentoforalcancer

Analysisofastandardizedapproach.JCraniomaxillofacSurg.2016441737-42. 11 CappielloJ,PiazzaC,GiudiceM,etal.Shoulderdisabilityafterdifferentselectiveneckdissections

levels-versuslevels-Vacomparativestudy.Laryngoscope.2005115259-63. 12 LiangL,ZhangT,KongQ,etal.Ameta-analysisonselectiveversuscomprehensiveneckdissection

inoralsquamouscellcarcinomapatientswithclinicallynode-positiveneck.OralOncol.2015511076-81.

N1 70 Pubmed Oral

carcinomaCarcinomaselectiveneckdissectionSOHNDN1NpositiveSupraomohyoidNeck

dissection313

CQ26

C3

2ICT1CDDP5-FU

ICT5PFSICT5746ICT32

ICTTPFICTRTICTRT3ICT80.6

009592-01_GL_04_01-05_DIC95_.indd 21 17/09/25 19:35

111/181

22

OS425N2ICT

ICT6-8ICT

1 LicitraL,GrandiC,GuzzoM,etal.Primarychemotherapy inresectableoralcavitysquamouscellcancerarandomizedcontrolledtrial.JClinOncol.200321327-33.

2 BossiP,LoVulloS,GuzzoM,etal.Preoperativechemotherapy inadvancedresectableOCSCClong-termresultsofarandomizedphasetrial.AnnOncol.201425462-6.

3 ZhongLP,ZhangCP,RenGX,etal.Randomizedphasetrial of inductionchemotherapywithdocetaxel,cisplatin,andfluorouracilfollowedbysurgeryversusup-frontsurgeryinlocallyadvancedresectableoralsquamouscellcarcinoma.JClinOncol.201331744-51.

4 ZhongLP,ZhangCP,RenGX,et al.Long-termresultsof a randomizedphasetrial ofTPFinductionchemotherapy followedbysurgeryandradiation in locallyadvancedoralsquamouscellcarcinoma.Oncotarget.201530618707-14.

5 MartaGN,RieraR,BossiP, et al. Induction chemotherapyprior to surgerywith orwithoutpostoperativeradiotherapy fororalcavitycancerpatientsSystematicreviewandmeta-analysis.EurJCancer.2015512596-603.

6 El-SayedS,NelsonN.Adjuvantandadjunctivechemotherapyinthemanagementofsquamouscellcarcinomaoftheheadandneckregion.Ameta-analysisofprospectiveandrandomizedtrials.JClinOncol.199614838-47.

7 PignonJP,BourhisJ,DomengeC,etal.Chemotherapyaddedtolocoregionaltreatmentforheadandneck squamous-cell carcinomathreemeta-analyses of updated individual data.MACH-NCCollaborativeGroup.Meta-AnalysisofChemotherapyonHeadandNeckCancer.Lancet.2000355949-55.

8 MaJ,LiuY,HuangXL,etal. Inductionchemotherapydecreases therateofdistantmetastasis inpatientswithheadandnecksquamouscellcarcinomabutdoesnotimprovesurvivalorlocoregionalcontrolameta-analysis.OralOncol.2012481076-84.

PubMed,Oralsquamouscellcarcinoma,neoadjuvantchemotherapy,preoperativechemotherapy

CQ27

C1

1,2

009592-01_GL_04_01-05_DIC95_.indd 22 17/09/25 19:35

112/181

-223

1,2,4-632

78QOL705,9

781,104,5,9, 11212

1 MatsuiY,ShirotaT,YamashitaK,etal.Analysesofspeechintelligibilityinpatientsafterglossectomyandreconstructionwithfasciocutaneousmyocutaneousflaps.IntJOralMaxillofacSurg.200938339-45.

2 BressmannT,SaderR,WhitegillTL,etal.Consonant intelligibilityandtonguemotility inpatientswithpartialglossectomy.JOralMaxillofacSurg.200462298-303.

3 200551391-402.

4 20107727-34. 5 NicolettiG,SoutarDS,JaksonMS,etal.Chewingandswallowingaftersurgical treatment fororal

cancerfunctionalevaluationin196selectedcases.PlastReconstrSurg.2004114329-38. 6 HellerKS,LevyJ,SciubbaJJ.Speechpatternsfollowingpartialglossectomyforsmalltumorsofthe

tongue.HeadNeck.199113340-3. 7 HsiaoHT, LeuYS, LinCC. Primary closure versus radial forearm flap reconstruction after

hemiglossectomyfunctionalassessmentofswallowingandspeech.AnnPlasticSurg.200249612-6.

8 SuWF,ChenSG,ShengH.Speechandswallowingfunctionafterreconstructionwitharadialforearmfreeflaporapectoralismajorflapfortonguecancer.JFormosMedAssoc.2002101472-7.

009592-01_GL_04_01-05_DIC95_.indd 23 17/09/25 19:35

113/181

24

9 Thankappan K, KuriakoseMA, Chatni SS, et al. Lateral Arm free flap for oral tongue

reconstructionananalysisofsurgicaldetails,morbidity,andfunctionalandaestheticoutcome.AnnPlastSurg.201166261-6.

10 ShpizerT,GuttmanD,GurE,etal.Transoral reconstructionof themobile tongue,usingradialforearmfreeflap.Microsurgery.20032318-20.

11 Hsiao HT, Leu YS, Lin CC. Tongue reconstruction with free radial forearm flap afterhemiglossectomyafunctionalassessment.JReconstrMicrosurg.200419137-42.

12 deVicente JC, deVillalan L,TorreA, et al.Microvascular free tissue transfer for tonguereconstructionafterhemiglossectomyafunctionalassessmentofradialforearmversusanterolateralthighflap.JOralMaxillofacSurg.2008662270-5.

PubMedheadandneckneoplasmstongueswallowingspeech464

103672

CQ

CQ28

B

QOLQOL

1-4volume1-4

volume70804-8Kimata3

009592-01_GL_04_01-05_DIC95_.indd 24 17/09/25 19:35

114/181

-225

Yun9

1 HaugheyBH.Tonguereconstructionconceptsandpractice.Laryngoscope.19931031132-41. 2 KiyokawaK,TaiY,InoueY,etal.Functionalreconstructionofswallowingandarticulationaftertotal

glossectomywithoutlaryngectomymoneypouch-likereconstructionmethodusingrectusabdominismyocutaneousflap.PlastReconstrSurg.19991042015-20.

3 KimataY,SakurabaM,HishinumaS, et al.Analysis of the relationsbetween the shapeof thereconstructedtongueandpostoperativefunctionsaftersubtotalandtotalglossectomy.Laryngoscope.2003113905-9.

4 YuP,RobbGL.Reconstructionfortotalandnear-totalglossectomydefects.ClinPlasticSurg.200532411-9.

5 LyosAT,EvansGR,PerezD,etal.Tonguereconstructionoutcomeswiththerectusabdominisflap.PlastReconstrSurg.1999103442-7discussion448-9.

6 KimataY,UchiyamaK,EbiharaS,etal.Postoperativecomplicationsandfunctionalresultsaftertotalglossectomywithmicrosurgicalreconstruction.PlastReconstrSurg.20001061028-35.

7 YanaiC,KikutaniT,AdachiM,etal.Functionaloutcomeaftertotalandsubtotalglossectomywithfreeflapreconstruction.HeadNeck.200830909-18.

8 VegaC,LeonX,CervelliD,etal.Totalorsubtotalglossectomywithmicrosurgicalreconstructionfunctionalandoncologicalresults.Microsurgery.201131517-23.

9 YunIS,LeeDW,LeeWJ,etal.Correlationofneotonguevolumechangeswithfunctionaloutcomesafterlong-termfollow-upoftotalglossectomy.JCraniofacSurg.201021111-6.

PubMedheadandneckneoplasmstongueswallowingspeech4647

367

2

009592-01_GL_04_01-05_DIC95_.indd 25 17/09/25 19:35

115/181

26

-3CQ

31

C1

C1

60801

2-4

51651,574,5

6,8,95

1 CarrauRL,SegasJ,NussDW,etal.Squamouscellcarcinomaof thesinonasal tract invadingtheorbit.Laryngoscope.1999109230-5.

2 NazarG,RodrigoJP,LlorenteJL,etal.Prognostic factorsofmaxillarysinusmalignancies.AmJRhinol.200418233-8.

3 CarrilloJF,GemesA,Ramrez-OrtegaMC,etal.Prognostic factors inmaxillarysinusandnasalcavitycarcinoma.EurJSurgOncol.2005311206-12.

4 SurezC,FerlitoA,LundVJ,etal.Managementof theorbit inmalignantsinonasal tumors.HeadNeck.200830242-50.

5 ImolaMJ,SchrammVLJr.Orbitalpreservation insurgicalmanagementofsinonasalmalignancy.

009592-01_GL_04_01-05_DIC95_.indd 26 17/09/25 19:35

116/181

-327

Laryngoscope.20021121357-65. 6 -

201137349-54 7 DulguerovP,JacobsenMS,AllalAS,etal.Nasalandparanasalsinuscarcinomaarewemaking

progress?Aseriesof220patientsandasystemicreview.Cancer.2001923012-29. 8 KanotoM,OdaA,HosoyaT,etal. Impactofsuperselectivetransarterial infusiontherapyofhigh-

dosecisplatinonmaxillarycancerwithorbitalinvasion.AJNRAmJNeuroradiol.2010311390-4. 9 NishinoH, IchimuraK,TanakaH, et al.Results of orbitalpreservation foradvancedmalignant

maxillarysinustumors.Laryngoscope.20031131064-9.

373PubMedsinonasalorbit127

maxillarysinuscancer1,456

CQ32

C1

12-4

IA-CRT-CRTlocoregion-alcontroldiseasefreesurvivaloverallsurvival-CRTIA-CRT45-CRTIA-CRT30ccIA-CRT

6-910,11N2b312,13

009592-01_GL_04_01-05_DIC95_.indd 27 17/09/25 19:35

117/181

28

IA-CRT

1 RobbinsKT,StornioloAM,KerberC,etal.Phase I studyofhighlyselectivesupradosecisplatininfusionsforadvancedheadandneckcancer.JClinOncol.1994122113-20.

2 RobbinsKT,VicarioD,SeagrenS,etal.Atargetedsupradosecisplatinchemoradiationprotocolforadvancedheadandneckcancer.AmJSurg.1994168419-22.

3 RobbinsKT,KumarP,HarrisJ,etal.Supradose intra-arterialcisplatinandconcurrentradiationtherapy for the treatment of stageheadandneck squamous cell carcinoma is feasible andefficaciousinamulti-institutionalsettingresultsofRadiationTherapyOncologyGroupTrial9615.JClinOncol.2005231447-54.

4 RaschCR,HauptmannM,SchornagelJ,etal. Intra-arterialversus intravenouschemoradiation foradvancedheadandneckcancerResultsofarandomizedphase3trial.Cancer.20101162159-65.

5 RobbinsKT,HowellSB,WilliamsJS.Intra-arterialchemotherapyforheadandneckcanceristhere

averdict?Cancer.20101162068-70. 6 ShigaK,YokoyamaJ,HashimotoS,etal.Combinedtherapyaftersuperselectivearterialcisplatin

infusiontotreatmaxillarysquamouscellcarcinoma.OtolaryngolHeadNeckSurg.20071361003-9.

7 HommaA,OridateN,SuzukiF,etal.Superselectivehigh-dosecisplatin infusionwithconcomitantradiotherapy inpatientswithadvancedcancerof thenasalcavityandparanasalsinusesasingleinstitutionexperience.Cancer.20091154705-14.

8 --201137498-502.

9 KanoS,HommaA,OridateN, et al. Superselectivearterial cisplatin infusionwithconcomitantradiationtherapyforbaseoftonguecancer.OralOncol.201147665-70.

10 YoshizakiT,KondoS,WakisakaN,etal.Concurrentintra-arterialchemotherapyandradiotherapyforadvancedlaryngealcancer.AnnOtolRhinolLaryngol.200911817